EP1236068A1 - Contact lens - Google Patents
Contact lensInfo
- Publication number
- EP1236068A1 EP1236068A1 EP00982514A EP00982514A EP1236068A1 EP 1236068 A1 EP1236068 A1 EP 1236068A1 EP 00982514 A EP00982514 A EP 00982514A EP 00982514 A EP00982514 A EP 00982514A EP 1236068 A1 EP1236068 A1 EP 1236068A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- monomer
- ester
- silyl group
- contact lens
- tris
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000178 monomer Substances 0.000 claims abstract description 726
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 150
- 239000000203 mixture Substances 0.000 claims abstract description 149
- -1 tris(siloxy)silyl group Chemical group 0.000 claims abstract description 108
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 95
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 91
- 239000001301 oxygen Substances 0.000 claims abstract description 91
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 91
- 125000003118 aryl group Chemical group 0.000 claims abstract description 66
- 238000000034 method Methods 0.000 claims abstract description 56
- 125000002091 cationic group Chemical group 0.000 claims abstract description 55
- 230000035699 permeability Effects 0.000 claims abstract description 46
- 239000000463 material Substances 0.000 claims abstract description 40
- 238000007334 copolymerization reaction Methods 0.000 claims abstract description 28
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 22
- 229920001577 copolymer Polymers 0.000 claims abstract description 20
- 230000008569 process Effects 0.000 claims abstract description 16
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 claims description 144
- 239000007983 Tris buffer Substances 0.000 claims description 121
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 claims description 102
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 82
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 81
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 71
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 56
- 150000001408 amides Chemical group 0.000 claims description 53
- 125000001153 fluoro group Chemical group F* 0.000 claims description 42
- 230000036571 hydration Effects 0.000 claims description 41
- 238000006703 hydration reaction Methods 0.000 claims description 41
- 239000003431 cross linking reagent Substances 0.000 claims description 37
- 150000002148 esters Chemical class 0.000 claims description 37
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims description 37
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 31
- 238000006116 polymerization reaction Methods 0.000 claims description 26
- 102000004169 proteins and genes Human genes 0.000 claims description 24
- 108090000623 proteins and genes Proteins 0.000 claims description 24
- 102000016943 Muramidase Human genes 0.000 claims description 21
- 108010014251 Muramidase Proteins 0.000 claims description 21
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 21
- 238000005266 casting Methods 0.000 claims description 21
- 239000004325 lysozyme Substances 0.000 claims description 21
- 235000010335 lysozyme Nutrition 0.000 claims description 21
- 229960000274 lysozyme Drugs 0.000 claims description 21
- 125000004432 carbon atom Chemical group C* 0.000 claims description 19
- 239000002904 solvent Substances 0.000 claims description 18
- 230000001747 exhibiting effect Effects 0.000 claims description 15
- 239000004971 Cross linker Substances 0.000 claims description 12
- 230000002035 prolonged effect Effects 0.000 claims description 10
- MNZNJOQNLFEAKG-UHFFFAOYSA-N 2-morpholin-4-ylethyl 2-methylprop-2-enoate Chemical group CC(=C)C(=O)OCCN1CCOCC1 MNZNJOQNLFEAKG-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000012062 aqueous buffer Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 230000006872 improvement Effects 0.000 claims description 4
- 125000004185 ester group Chemical group 0.000 claims 22
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 10
- 238000001816 cooling Methods 0.000 claims 1
- 230000000887 hydrating effect Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 6
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 35
- 238000009472 formulation Methods 0.000 description 34
- 229920000642 polymer Polymers 0.000 description 21
- 102000015728 Mucins Human genes 0.000 description 19
- 108010063954 Mucins Proteins 0.000 description 19
- 229920001296 polysiloxane Polymers 0.000 description 19
- 210000004087 cornea Anatomy 0.000 description 13
- 239000012530 fluid Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- ZAZJGBCGMUKZEL-UHFFFAOYSA-N 2-[ethyl(1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctylsulfonyl)amino]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCN(CC)S(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F ZAZJGBCGMUKZEL-UHFFFAOYSA-N 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 9
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 230000004907 flux Effects 0.000 description 9
- 239000003999 initiator Substances 0.000 description 9
- 238000005102 attenuated total reflection Methods 0.000 description 8
- 238000001228 spectrum Methods 0.000 description 8
- ZTHJQCDAHYOPIK-UHFFFAOYSA-N 3-methylbut-2-en-2-ylbenzene Chemical compound CC(C)=C(C)C1=CC=CC=C1 ZTHJQCDAHYOPIK-UHFFFAOYSA-N 0.000 description 7
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate group Chemical group C(C=C)(=O)[O-] NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000011088 calibration curve Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 6
- LVJZCPNIJXVIAT-UHFFFAOYSA-N 1-ethenyl-2,3,4,5,6-pentafluorobenzene Chemical compound FC1=C(F)C(F)=C(C=C)C(F)=C1F LVJZCPNIJXVIAT-UHFFFAOYSA-N 0.000 description 5
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 description 5
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 5
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- NZIDBRBFGPQCRY-UHFFFAOYSA-N octyl 2-methylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C(C)=C NZIDBRBFGPQCRY-UHFFFAOYSA-N 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2,2'-azo-bis-isobutyronitrile Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- QTKPMCIBUROOGY-UHFFFAOYSA-N 2,2,2-trifluoroethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(F)(F)F QTKPMCIBUROOGY-UHFFFAOYSA-N 0.000 description 4
- LEJBBGNFPAFPKQ-UHFFFAOYSA-N 2-(2-prop-2-enoyloxyethoxy)ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOC(=O)C=C LEJBBGNFPAFPKQ-UHFFFAOYSA-N 0.000 description 4
- HCLJOFJIQIJXHS-UHFFFAOYSA-N 2-[2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOCCOC(=O)C=C HCLJOFJIQIJXHS-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 239000004809 Teflon Substances 0.000 description 4
- 229920006362 Teflon® Polymers 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- 239000003618 borate buffered saline Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 239000000017 hydrogel Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
- FMQPBWHSNCRVQJ-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C(F)(F)F)C(F)(F)F FMQPBWHSNCRVQJ-UHFFFAOYSA-N 0.000 description 3
- CORMBJOFDGICKF-UHFFFAOYSA-N 1,3,5-trimethoxy 2-vinyl benzene Natural products COC1=CC(OC)=C(C=C)C(OC)=C1 CORMBJOFDGICKF-UHFFFAOYSA-N 0.000 description 3
- DBCGADAHIXJHCE-UHFFFAOYSA-N 2-[ethyl(1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctylsulfonyl)amino]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCN(CC)S(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F DBCGADAHIXJHCE-UHFFFAOYSA-N 0.000 description 3
- PDELBHCVXBSVPJ-UHFFFAOYSA-N 2-ethenyl-1,3,5-trimethylbenzene Chemical compound CC1=CC(C)=C(C=C)C(C)=C1 PDELBHCVXBSVPJ-UHFFFAOYSA-N 0.000 description 3
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 3
- BESKSSIEODQWBP-UHFFFAOYSA-N 3-tris(trimethylsilyloxy)silylpropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC[Si](O[Si](C)(C)C)(O[Si](C)(C)C)O[Si](C)(C)C BESKSSIEODQWBP-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229910001369 Brass Inorganic materials 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000010587 phase diagram Methods 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000012460 protein solution Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- SBIBMFFZSBJNJF-UHFFFAOYSA-N selenium;zinc Chemical compound [Se]=[Zn] SBIBMFFZSBJNJF-UHFFFAOYSA-N 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- MNSWITGNWZSAMC-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl prop-2-enoate Chemical compound FC(F)(F)C(C(F)(F)F)OC(=O)C=C MNSWITGNWZSAMC-UHFFFAOYSA-N 0.000 description 2
- ZDQNWDNMNKSMHI-UHFFFAOYSA-N 1-[2-(2-prop-2-enoyloxypropoxy)propoxy]propan-2-yl prop-2-enoate Chemical compound C=CC(=O)OC(C)COC(C)COCC(C)OC(=O)C=C ZDQNWDNMNKSMHI-UHFFFAOYSA-N 0.000 description 2
- QEDJMOONZLUIMC-UHFFFAOYSA-N 1-tert-butyl-4-ethenylbenzene Chemical compound CC(C)(C)C1=CC=C(C=C)C=C1 QEDJMOONZLUIMC-UHFFFAOYSA-N 0.000 description 2
- QJEJDNMGOWJONG-UHFFFAOYSA-N 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoroheptyl prop-2-enoate Chemical compound FC(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)COC(=O)C=C QJEJDNMGOWJONG-UHFFFAOYSA-N 0.000 description 2
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 2
- DXIJHCSGLOHNES-UHFFFAOYSA-N 3,3-dimethylbut-1-enylbenzene Chemical compound CC(C)(C)C=CC1=CC=CC=C1 DXIJHCSGLOHNES-UHFFFAOYSA-N 0.000 description 2
- ZIFLDVXQTMSDJE-UHFFFAOYSA-N 3-[[dimethyl-[3-(2-methylprop-2-enoyloxy)propyl]silyl]oxy-dimethylsilyl]propyl 2-methylprop-2-enoate Chemical group CC(=C)C(=O)OCCC[Si](C)(C)O[Si](C)(C)CCCOC(=O)C(C)=C ZIFLDVXQTMSDJE-UHFFFAOYSA-N 0.000 description 2
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 2
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 description 2
- PPBAWVJOPQUAMY-UHFFFAOYSA-N 3-tris(trimethylsilyloxy)silylpropyl prop-2-enoate Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)CCCOC(=O)C=C PPBAWVJOPQUAMY-UHFFFAOYSA-N 0.000 description 2
- YKXAYLPDMSGWEV-UHFFFAOYSA-N 4-hydroxybutyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCO YKXAYLPDMSGWEV-UHFFFAOYSA-N 0.000 description 2
- NDWUBGAGUCISDV-UHFFFAOYSA-N 4-hydroxybutyl prop-2-enoate Chemical compound OCCCCOC(=O)C=C NDWUBGAGUCISDV-UHFFFAOYSA-N 0.000 description 2
- ZLQGITSKRNWIOT-UHFFFAOYSA-N 5-(dimethylamino)furan-2-carbaldehyde Chemical compound CN(C)C1=CC=C(C=O)O1 ZLQGITSKRNWIOT-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 239000010951 brass Substances 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- CHEFFAKKAFRMHG-UHFFFAOYSA-N ethenyl-tris(trimethylsilyloxy)silane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C=C CHEFFAKKAFRMHG-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000012447 hatching Effects 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 230000010220 ion permeability Effects 0.000 description 2
- 230000005865 ionizing radiation Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229960004592 isopropanol Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 2
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 2
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000010526 radical polymerization reaction Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012719 thermal polymerization Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- WCAXVXQTTCIZHD-UHFFFAOYSA-N trimethyl-[prop-2-enyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](CC=C)(O[Si](C)(C)C)O[Si](C)(C)C WCAXVXQTTCIZHD-UHFFFAOYSA-N 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- AAWMNZVMKVXTOE-UHFFFAOYSA-N (2-amino-2-oxoethyl) 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(N)=O AAWMNZVMKVXTOE-UHFFFAOYSA-N 0.000 description 1
- SSWULJQUZSLYNA-UHFFFAOYSA-N (2-methylpropanoylamino)methyl 2-methylprop-2-enoate Chemical compound CC(C(=O)NCOC(C(=C)C)=O)C SSWULJQUZSLYNA-UHFFFAOYSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- CMHULLZFVLTEFN-UHFFFAOYSA-N 1,1,2,2,2-pentafluoroethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(F)(F)C(F)(F)F CMHULLZFVLTEFN-UHFFFAOYSA-N 0.000 description 1
- GYXUNDYSSCDRAG-UHFFFAOYSA-N 1,1,2,2,2-pentafluoroethyl prop-2-enoate Chemical compound FC(F)(F)C(F)(F)OC(=O)C=C GYXUNDYSSCDRAG-UHFFFAOYSA-N 0.000 description 1
- MYWOJODOMFBVCB-UHFFFAOYSA-N 1,2,6-trimethylphenanthrene Chemical compound CC1=CC=C2C3=CC(C)=CC=C3C=CC2=C1C MYWOJODOMFBVCB-UHFFFAOYSA-N 0.000 description 1
- KQAQJORNWGFUKW-UHFFFAOYSA-N 1-(2-ethenoxyethyl)piperidine Chemical compound C=COCCN1CCCCC1 KQAQJORNWGFUKW-UHFFFAOYSA-N 0.000 description 1
- WUIJTQZXUURFQU-UHFFFAOYSA-N 1-methylsulfonylethene Chemical compound CS(=O)(=O)C=C WUIJTQZXUURFQU-UHFFFAOYSA-N 0.000 description 1
- XLPJNCYCZORXHG-UHFFFAOYSA-N 1-morpholin-4-ylprop-2-en-1-one Chemical compound C=CC(=O)N1CCOCC1 XLPJNCYCZORXHG-UHFFFAOYSA-N 0.000 description 1
- RESPXSHDJQUNTN-UHFFFAOYSA-N 1-piperidin-1-ylprop-2-en-1-one Chemical compound C=CC(=O)N1CCCCC1 RESPXSHDJQUNTN-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- GZEXHGDBYMTBCP-UHFFFAOYSA-N 2-carbamoyloxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC(N)=O GZEXHGDBYMTBCP-UHFFFAOYSA-N 0.000 description 1
- AKVUWTYSNLGBJY-UHFFFAOYSA-N 2-methyl-1-morpholin-4-ylprop-2-en-1-one Chemical compound CC(=C)C(=O)N1CCOCC1 AKVUWTYSNLGBJY-UHFFFAOYSA-N 0.000 description 1
- RASDUGQQSMMINZ-UHFFFAOYSA-N 2-methyl-1-piperidin-1-ylprop-2-en-1-one Chemical compound CC(=C)C(=O)N1CCCCC1 RASDUGQQSMMINZ-UHFFFAOYSA-N 0.000 description 1
- LMLSCFIXZXYRJX-UHFFFAOYSA-N 2-methyl-N-[1,3,3-tris[[dimethyl(phenyl)silyl]oxy]-3-silylpropyl]prop-2-enamide Chemical compound C(C(=C)C)(=O)NC(CC([SiH3])(O[Si](C)(C)C1=CC=CC=C1)O[Si](C)(C)C1=CC=CC=C1)O[Si](C1=CC=CC=C1)(C)C LMLSCFIXZXYRJX-UHFFFAOYSA-N 0.000 description 1
- KPZALMLCYGHIGM-UHFFFAOYSA-N 2-methyl-N-[1,3,3-tris[[dimethyl(propyl)silyl]oxy]-3-silylpropyl]prop-2-enamide Chemical compound C[Si](OC(CC([SiH3])(O[Si](C)(C)CCC)O[Si](C)(C)CCC)NC(C(=C)C)=O)(CCC)C KPZALMLCYGHIGM-UHFFFAOYSA-N 0.000 description 1
- IJSVVICYGLOZHA-UHFFFAOYSA-N 2-methyl-n-phenylprop-2-enamide Chemical compound CC(=C)C(=O)NC1=CC=CC=C1 IJSVVICYGLOZHA-UHFFFAOYSA-N 0.000 description 1
- UWRZIZXBOLBCON-UHFFFAOYSA-N 2-phenylethenamine Chemical compound NC=CC1=CC=CC=C1 UWRZIZXBOLBCON-UHFFFAOYSA-N 0.000 description 1
- KXYAVSFOJVUIHT-UHFFFAOYSA-N 2-vinylnaphthalene Chemical compound C1=CC=CC2=CC(C=C)=CC=C21 KXYAVSFOJVUIHT-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- HKADMMFLLPJEAG-UHFFFAOYSA-N 3,3,3-trifluoroprop-1-enylbenzene Chemical compound FC(F)(F)C=CC1=CC=CC=C1 HKADMMFLLPJEAG-UHFFFAOYSA-N 0.000 description 1
- IUUBODMNDCMSEU-UHFFFAOYSA-N 3-[6-amino-3-(3-hydroxypropyl)-2,4,5,9-tetrahydropurin-2-yl]propan-1-ol Chemical compound NC1=NC(CCCO)N(CCCO)C2N=CNC12 IUUBODMNDCMSEU-UHFFFAOYSA-N 0.000 description 1
- JCMFXEIQKSSNTG-UHFFFAOYSA-N 3-[[3-(2-methylprop-2-enoyloxy)propyl-bis(trimethylsilyloxy)silyl]oxy-bis(trimethylsilyloxy)silyl]propyl 2-methylprop-2-enoate Chemical group CC(=C)C(=O)OCCC[Si](O[Si](C)(C)C)(O[Si](C)(C)C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)CCCOC(=O)C(C)=C JCMFXEIQKSSNTG-UHFFFAOYSA-N 0.000 description 1
- JVZCWIAIYUEMBR-UHFFFAOYSA-N 3-tris[[dimethyl(trimethylsilyloxy)silyl]oxy]silylpropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC[Si](O[Si](C)(C)O[Si](C)(C)C)(O[Si](C)(C)O[Si](C)(C)C)O[Si](C)(C)O[Si](C)(C)C JVZCWIAIYUEMBR-UHFFFAOYSA-N 0.000 description 1
- KFDVPJUYSDEJTH-UHFFFAOYSA-N 4-ethenylpyridine Chemical compound C=CC1=CC=NC=C1 KFDVPJUYSDEJTH-UHFFFAOYSA-N 0.000 description 1
- JHWGFJBTMHEZME-UHFFFAOYSA-N 4-prop-2-enoyloxybutyl prop-2-enoate Chemical compound C=CC(=O)OCCCCOC(=O)C=C JHWGFJBTMHEZME-UHFFFAOYSA-N 0.000 description 1
- FIHBHSQYSYVZQE-UHFFFAOYSA-N 6-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCOC(=O)C=C FIHBHSQYSYVZQE-UHFFFAOYSA-N 0.000 description 1
- 238000004483 ATR-FTIR spectroscopy Methods 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- HVVWZTWDBSEWIH-UHFFFAOYSA-N [2-(hydroxymethyl)-3-prop-2-enoyloxy-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical compound C=CC(=O)OCC(CO)(COC(=O)C=C)COC(=O)C=C HVVWZTWDBSEWIH-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000003732 agents acting on the eye Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- GTBGXKPAKVYEKJ-UHFFFAOYSA-N decyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C(C)=C GTBGXKPAKVYEKJ-UHFFFAOYSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- WQZGKKKJIJFFOK-UKLRSMCWSA-N dextrose-2-13c Chemical compound OC[C@H]1OC(O)[13C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-UKLRSMCWSA-N 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- LNMQRPPRQDGUDR-UHFFFAOYSA-N hexyl prop-2-enoate Chemical compound CCCCCCOC(=O)C=C LNMQRPPRQDGUDR-UHFFFAOYSA-N 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 125000005641 methacryl group Chemical group 0.000 description 1
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 description 1
- RXRHXOLQBOFMDI-UHFFFAOYSA-N methoxymethane;2-methylprop-2-enoic acid Chemical compound COC.CC(=C)C(O)=O RXRHXOLQBOFMDI-UHFFFAOYSA-N 0.000 description 1
- IHBKAGRPNRKYAO-UHFFFAOYSA-M methyl sulfate;trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium Chemical compound COS([O-])(=O)=O.CC(=C)C(=O)OCC[N+](C)(C)C IHBKAGRPNRKYAO-UHFFFAOYSA-M 0.000 description 1
- WFKDPJRCBCBQNT-UHFFFAOYSA-N n,2-dimethylprop-2-enamide Chemical compound CNC(=O)C(C)=C WFKDPJRCBCBQNT-UHFFFAOYSA-N 0.000 description 1
- QRWZCJXEAOZAAW-UHFFFAOYSA-N n,n,2-trimethylprop-2-enamide Chemical compound CN(C)C(=O)C(C)=C QRWZCJXEAOZAAW-UHFFFAOYSA-N 0.000 description 1
- RKSYJNCKPUDQET-UHFFFAOYSA-N n,n-dipropylprop-2-enamide Chemical compound CCCN(CCC)C(=O)C=C RKSYJNCKPUDQET-UHFFFAOYSA-N 0.000 description 1
- OKPYIWASQZGASP-UHFFFAOYSA-N n-(2-hydroxypropyl)-2-methylprop-2-enamide Chemical compound CC(O)CNC(=O)C(C)=C OKPYIWASQZGASP-UHFFFAOYSA-N 0.000 description 1
- UDPGDOVLROZTJY-UHFFFAOYSA-N n-benzyl-2-methylprop-2-enamide;n-decyl-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NCC1=CC=CC=C1.CCCCCCCCCCNC(=O)C(C)=C UDPGDOVLROZTJY-UHFFFAOYSA-N 0.000 description 1
- PNLUGRYDUHRLOF-UHFFFAOYSA-N n-ethenyl-n-methylacetamide Chemical compound C=CN(C)C(C)=O PNLUGRYDUHRLOF-UHFFFAOYSA-N 0.000 description 1
- AWGZKFQMWZYCHF-UHFFFAOYSA-N n-octylprop-2-enamide Chemical compound CCCCCCCCNC(=O)C=C AWGZKFQMWZYCHF-UHFFFAOYSA-N 0.000 description 1
- BPCNEKWROYSOLT-UHFFFAOYSA-N n-phenylprop-2-enamide Chemical class C=CC(=O)NC1=CC=CC=C1 BPCNEKWROYSOLT-UHFFFAOYSA-N 0.000 description 1
- XFHJDMUEHUHAJW-UHFFFAOYSA-N n-tert-butylprop-2-enamide Chemical compound CC(C)(C)NC(=O)C=C XFHJDMUEHUHAJW-UHFFFAOYSA-N 0.000 description 1
- 229920005787 opaque polymer Polymers 0.000 description 1
- 229940023490 ophthalmic product Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000002669 organ and tissue protective effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- BOQSSGDQNWEFSX-UHFFFAOYSA-N propan-2-yl 2-methylprop-2-enoate Chemical compound CC(C)OC(=O)C(C)=C BOQSSGDQNWEFSX-UHFFFAOYSA-N 0.000 description 1
- LYBIZMNPXTXVMV-UHFFFAOYSA-N propan-2-yl prop-2-enoate Chemical compound CC(C)OC(=O)C=C LYBIZMNPXTXVMV-UHFFFAOYSA-N 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 150000003254 radicals Chemical group 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 125000005401 siloxanyl group Chemical group 0.000 description 1
- WIJVUKXVPNVPAQ-UHFFFAOYSA-N silyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)O[SiH3] WIJVUKXVPNVPAQ-UHFFFAOYSA-N 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229940072768 sodium chloride irrigation solution Drugs 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 150000003512 tertiary amines Chemical group 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 235000019756 total sulphur amino acid Nutrition 0.000 description 1
- KAKFZMMRKBQABS-UHFFFAOYSA-N trimethyl(silyloxysilyloxy)silane Chemical compound C[Si](C)(C)O[SiH2]O[SiH3] KAKFZMMRKBQABS-UHFFFAOYSA-N 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 125000002348 vinylic group Chemical group 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/52—Amides or imides
- C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
- C08F220/56—Acrylamide; Methacrylamide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F230/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
- C08F230/04—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing a metal
- C08F230/08—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing a metal containing silicon
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S525/00—Synthetic resins or natural rubbers -- part of the class 520 series
- Y10S525/937—Utility as body contact e.g. implant, contact lens or I.U.D.
Definitions
- This invention relates broadly to lenses and polymeric materials useful in optic and ophthalmic arts. More specifically, this invention relates to polymeric materials, contact lenses and treatment processes useful in the manufacture of contact lenses.
- biocompatible depends on the particular application for which the polymer is designed.
- a biocompatible lens is generally defined as one that does not substantially damage the surrounding ocular tissue and ocular fluid during the time period of contact.
- ophthalmically compatible more appropriately describes the biocompatibility requirements of ophthalmic lenses.
- the lens permits oxygen to reach the cornea in an amount that is sufficient for long-term corneal health.
- the contact lens should permit oxygen from the surrounding air to reach the cornea because the cornea does not receive oxygen from the blood supply like other tissues. If sufficient oxygen does not reach the cornea, corneal swelling can occur, as can epithelial microcysts, stromal/epithelial thinning, stromal acidosis, endothelial polymegethism, corneal ulcers and increased inflammation.
- Soft contact lenses conform closely to the shape of the eye, so oxygen cannot easily circumvent the lens. Thus, soft contact lenses should permit oxygen to diffuse through the lens to reach the cornea.
- Another ophthalmic compatibility feature for soft contact lenses is that the lens not adhere strongly to the eye.
- the consumer should be able to easily remove the lens from the eye for disinfecting, cleaning or disposal.
- the lens should also be able to move on the eye in order to encourage tear flow between the lens and the eye. Tear flow between the lens and eye permits debris, such as foreign particulates or dead epithelial cells, to be swept from beneath the lens and, ultimately, out of the eye in tear fluid.
- a contact lens should not adhere to the eye so strongly that adequate movement of the lens on the eye is inhibited.
- RGP gas permeable
- HEMA 2 -hydroxyethyl methacrylate
- GMA N-vinyl pyrrolidone
- GMA glyceryl methacrylate
- the present invention contemplates an ophthalmic lens comprising a polymeric material that has an oxygen permeability of about 45 to about 150 Dk units and a hydrated water content of about 20 to about 55 weight percent.
- the polymeric material is comprised of a co-polymer of (a) a hydrophilic monomer, (b) a hydrophobic (aromatic, aliphatic or mixture) monomer, (c) a tris (siloxy) silyl group-containing monomer, (d) a fluorinated monomer containing about 3 to about 20 fluorine atoms per monomer molecule (a polyfluorinated monomer) and (e) an amount of cross-linker sufficient to provide a stress at break value of about 0.003 to about 30
- Another polymeric contact lens material comprises a co-polymer of polymerized (a) non-ionic hydrophilic monomer, (b) hydrophobic (aromatic, aliphatic or mixture) monomer, (c) tris (siloxy) silyl group-containing monomer, (d) fluorinated monomer containing about 3 to about 20 fluorine atoms per monomer molecule (polyfluorinated monomer) and (e) cross- linking agent.
- the weight ratio of the tris (siloxy) silyl group-containing monomer to the non-ionic hydrophilic monomer is about 0.3:1 to about 2:1.
- the lens material exhibits an oxygen permeability of greater than about 60 Dk units and a water content at equilibrium hydration of about 20 to about 55, and preferably about 35 to about 55 weight percent.
- a further embodiment contemplates a polymeric contact lens comprising a co-polymerized (a) non-ionic hydrophilic monomer containing a methacrylamide, an acrylamide, a methacrylate or an acrylate group, (b) a hydrophobic (aromatic, aliphatic or mixture) monomer, (c) a tris (siloxy) silyl group-containing monomer, (d) a fluorinated monomer containing about 3 to about 20 fluorine atoms per monomer molecule (polyfluorinated monomer) and (e) cross- linking agent.
- a co-polymerized (a) non-ionic hydrophilic monomer containing a methacrylamide, an acrylamide, a methacrylate or an acrylate group, (b) a hydrophobic (aromatic, aliphatic or mixture) monomer, (c) a tris (siloxy) silyl group-containing monomer, (d) a fluorin
- the weight ratio of the tris (siloxy) silyl group-containing monomer to the non-ionic hydrophilic monomer is about 0.3:1 to about 2:1.
- This lens exhibits an oxygen transmissibility of about 60 to about 150 Dk units and a water content at equilibrium hydration of about 20 to about 55, and preferably about 35 to about 55 weight percent.
- Yet another polymeric contact lens comprises co- polymerized (a) non- ionic hydrophilic monomer containing a methacrylamide, an acrylamide, a methacrylate ester or an acrylate ester group, (b) fluorinated monomer containing about 3 to about 20 fluorine atoms per monomer molecule (polyfluorinated monomer), (c) tris (siloxy) silyl group- containing monomer, (d) styrene-containing monomer and (e) cross-linking agent.
- the weight ratio of the tris (siloxy) silyl group-containing monomer to the non-ionic hydrophilic monomer is about 0.3:1 to about 2:1.
- the lens exhibits an oxygen transmissibility of about 45 to about 150 Dk units and a water content at equilibrium hydration of about 20 to about 55, and preferably about 35 to about 55 weight percent .
- a still further polymeric contact lens comprises co- polymerized (a) non-ionic hydrophilic monomer containing a methacrylamide, an acrylamide, a methacrylate ester or an acrylate ester group, (b) fluorinated monomer containing about 3 to about 20 fluorine atoms per monomer molecule (polyfluorinated monomer), (c) tris (siloxy) silyl group- containing monomer, (d) a hydrophobic methacrylate or acrylate monomer and (e) cross-linking agent.
- the weight ratio of the tris (siloxy) silyl group-containing monomer to the non-ionic hydrophilic monomer is about 0.3:1 to about 2:1.
- the lens exhibits an oxygen transmissibility of about 50 to about 150 Dk units and a water content at equilibrium hydration of about 20 to about 55, and preferably about 35 to about 55 weight percent .
- a further contact lens is the co-polymerization product of a monomer mixture comprising (a) a non-ionic hydrophilic monomer, (b) a tris (siloxy) silyl group-containing monomer, (c) a hydrophobic aromatic monomer such as a styrene- containing monomer, (d) a polyfluorinated monomer, a cationic monomer, a hydrophobic non-aromatic monomer or a mixture of two or three of those monomer types and (e) a cross-linking agent.
- a monomer mixture comprising (a) a non-ionic hydrophilic monomer, (b) a tris (siloxy) silyl group-containing monomer, (c) a hydrophobic aromatic monomer such as a styrene- containing monomer, (d) a polyfluorinated monomer, a cationic monomer, a hydrophobic non-aromatic monomer or a mixture of two or
- the monomer mixture includes a weight ratio of tris (siloxy) silyl group-containing monomer to hydrophilic monomer of about 0.3:1 to about 2:1, and a weight ratio of tris (siloxy) silyl group-containing monomer to a single monomer or monomer mixture of (d) of about 1.5:1 to about 20:1.
- This lens also exhibits an oxygen transmissibility of about 45 to about 150 Dk units and a water content at equilibrium hydration of about 35 to about 55 weight percent.
- a still further contact lens is the co- polymerization product of a monomer mixture comprising (a) a non-ionic hydrophilic monomer, (b) a cationic monomer, (c) a tris (siloxy) silyl group-containing monomer, (d) a hydrophobic aromatic monomer such as a styrene-containing monomer, and (e) a cross-linking agent.
- the monomer mixture includes a weight ratio of tris (siloxy) silyl group-containing monomer to hydrophilic monomer of about 0.3:1 to about 2:1.
- This lens also exhibits an oxygen transmissibility of greater than 45 Dk units and a water content at equilibrium hydration of about 35 to about 55 weight percent .
- a co-polymerization product of a monomer mixture comprising (a) a non-ionic hydrophilic monomer, (b) a poly (dimethylsiloxy) silyl group-containing monomer, (c) a tris (siloxy) silyl group-containing monomer, (d) a hydrophobic monomer, and (e) a cross-linking agent comprises yet another contemplated contact lens.
- the monomer mixture includes a weight ratio of tris (siloxy) silyl group-containing monomer to hydrophilic monomer of about 0.3:1 to about 2:1, and exhibits a water content on equilibrium hydration of at least 20 weight percent to about 55 weight percent and an oxygen permeation value of about 55 to about 120 Dk units.
- a contact lens that comprises a co-polymer of (a) a non-ionic hydrophilic monomer, (b) a tris (siloxy) silyl group- containing monomer, (c) a cationic monomer, (d) a polyfluorinated monomer, a poly- (dimethylsiloxy) silyl monomer, a hydrophobic monomer (aromatic or non-aromatic monomer) or a mixture of two or three of those monomer types and (e) a cross-linking agent is also contemplated.
- This lens exhibits an oxygen transmissibility of about 45 to about 150 Dk units, and a water content at equilibrium hydration of about 20 to about 55, and preferably about 35 to about 55 weight percent.
- the lens separately binds mucin and lysozyme in vi tro at a ratio by weight of about 1:2 to about 2:1 and in an amount of about 0.75 to about 2.5 ⁇ g/cm 2 , when those proteins are separately present at initial concentrations of 0.46 g/L in aqueous buffers at a pH value of 7.2-7.6.
- a polymerization process (or method) is also contemplated.
- an ophthalmic contact lens is prepared by the co-polymerization of a monomer mixture that is thermally polymerized in a filled and closed casting cup for time period of about ten to about fifteen minutes at a temperature of about 110 to about 140°C, and more preferably at about 120 to about 135°C.
- a contemplated monomer mixture comprises (a) a hydrophilic unsubstituted, mono- or disubstituted C ] _-C4 -alkyl acrylamide or methacrylamide monomer,
- a tris (siloxy) silyl group-containing monomer (b) a tris (siloxy) silyl group-containing monomer, (c) a polyfluorinated monomer, a cationic monomer, a hydrophobic non-aromatic monomer, hydrophobic aromatic monomer or a poly (dimethylsiloxy) silyl group-containing monomer or a mixture of two, three, four or five of those monomer types and
- a further process contemplates an improvement in forming ophthalmic lenses by co-polymerization of a monomer mixture that comprises (a) a non-ionic hydrophilic monomer that is a methacrylamide or acrylamide and (b) a tris (siloxy) silyl group-containing monomer.
- the improvement comprises wet casting the lenses from a composition that includes those monomers and a non-co-polymerizable solvent that is miscible in the monomer mixture and is readily removable from the co-polymerized lens.
- the monomer mixture also includes (c) a poly- (dimethylsiloxy) silyl monomer.
- the present invention has several benefits and advantages .
- An advantage of the invention is the provision of an ophthalmic lens that provides oxygen sufficient to permit wear of the lens without inflammation or infection for prolonged periods of time.
- One benefit of the invention is the provision of an ophthalmic lens that provides water content sufficient to permit wear of the lens without inflammation or infection for prolonged periods of time.
- Fig. 1 is a cross-sectional view of the lens holder apparatus for measuring the water flux through a contact lens
- Fig 2 is a graph of oxygen permeability values (Dk units) versus DMA:T1 (dimethylacrylamide : TI) content of contact lenses for lenses containing 3.5 weight percent MD9 (a monomethacryloxypropyl-terminated polydimethylsiloxane having a molecular weight of about 1000) , as well as two lenses containing 7 and 56 weight percent MD9 and having a DMA:T1 [TI, also sometimes referred to as TRIS, is methacryloxypropyltris (trimethylsiloxy) silane] ratio of 1;
- Fig. 3 is a graph of water content as weight percent versus DMA:T1 content for the lenses of Fig. 2, and in which water contents below about 30 weight percent are estimated;
- Fig. 4 is a phase diagram for the system MD9/TRIS/DMA wherein all numbers are in weight percents, horizontal hatching represents a hazy monomer mixture and polymer, vertical hatching represents creamy monomer composition and opaque polymer, and the remaining compositions of monomer and polymer within the diagram are clear.
- the term "monomer” as used herein, refers to a compound that can either be polymerized, or that can be co- polymerized with other monomers under polymerization conditions .
- cationic monomer refers to a monomer having a pendent functional group that exhibits a cationic (positive) charge either permanently or through protonation in water at physiological pH values; i.e., pH 7.2- 7.4.
- polymerization conditions refers to conditions under which the polymerization of one or more monomers into a polymer is accomplished. Suitable conditions are well-known in the art and can include use of an activator or initiator such as (2 , 2 -azobisisobutyronitrile (AIBN) , use of UV or ionizing radiation, use of heat, use of microwave energy, or combinations thereof to initiate and propagate the free-radical polymerization chain reaction.
- an activator or initiator such as (2 , 2 -azobisisobutyronitrile (AIBN)
- AIBN 2 -azobisisobutyronitrile
- copolymer refers to a polymer prepared from two or more monomers, or the reaction in which those two or more monomers react, and a monomer's ability to be polymerized with at least one other monomer, respectively. These terms are not limited to only a two monomer polymer system.
- an "ophthalmic lens” refers to a lens placed in intimate contact with the eye or tear fluid, such as contact lenses for vision correction (e.g., spherical, toric, bifocal), contact lenses for modification of eye color, ophthalmic drug delivery devices, ocular tissue protective devices (e.g., ophthalmic healing promoting lenses), and the like.
- a particularly preferred ophthalmic lens is a contact lens for vision correction.
- these materials will be referred to herein as “polymerizable materials” and the resultant polymers will be referred to herein as "ophthalmic polymers”.
- oxygen permeability of a lens is the rate at which oxygen will pass through a specific ophthalmic lens. Units of oxygen permeability are expressed in "barrers”, where a “barrer” is defined as:
- Optically compatible refers to a material or surface of a material that can be in intimate contact with the ocular environment for an prolonged period of time without significantly damaging the ocular environment and without significant user discomfort.
- an ophthalmically compatible contact lens does not produce significant corneal swelling, adequately moves on the eye with blinking to promote sufficient tear exchange, does not have substantial amounts of lipid or protein adsorption, and does not cause substantial wearer discomfort during the prescribed period of wear.
- Optacular environment refers to ocular fluids (e.g., tear fluid) and ocular tissue (e.g., the cornea) that come into intimate contact with a contact lens used for vision correction, drug delivery, wound healing, eye color modification or other ophthalmic applications.
- ocular fluids e.g., tear fluid
- ocular tissue e.g., the cornea
- Hydrophilic as used herein, describes a material or portion thereof that readily associates with water.
- the word “hydrophilic” derives from the Latin meaning water-loving but, herein shall mean as described above.
- Hydrophobic as used herein, describes a material or portion thereof that does not readily associate with water.
- the word “hydrophobic” derives from the Latin meaning water hating but, herein shall mean as described above.
- hydrophilic surface refers to a surface upon which water spreads or that is wet by water.
- the "outer surface” of a lens refers to the surface of the lens that faces away from the eye during wear.
- the outer surface which is typically substantially convex, can also be referred to as the front curve of the lens.
- the “inner surface” of a lens refers to the surface of the lens that faces towards the eye during wear.
- the inner surface which is typically substantially concave, can also be referred to as the base curve of the lens.
- the present invention is directed to an ophthalmic lens that is suited to prolonged periods of wear in continuous, intimate contact with ocular tissue and ocular fluids.
- a contemplated ophthalmic lens comprises a polymeric material that has an oxygen permeability of about 45 to about 150 Dk and a hydrated water content of about 20 to about 55 weight percent, and preferably about 35 to about 55 weight percent .
- a contemplated lens can be surface treated as by plasma treatment or chemical reaction to enhance wearing time.
- the polymeric material is comprised of a co-polymer of (a) a hydrophilic polymerizable material, (b) a hydrophobic (aromatic, aliphatic or mixture) monomer, (c) a tris (siloxy) silyl group-containing monomer, (d) a fluorinated monomer containing about 3 to about 20 fluorine atoms per monomer molecule and (e) an amount of cross-linker sufficient to provide a stress at break value of about 0.003 to about 30 N/mm 2 , elongation at break of about 25 to about 3000 percent and a modulus value of about 0.001 to about 10 N/mm 2 .
- a contemplated lens permits oxygen permeation in an amount sufficient to maintain corneal health and wearer comfort during a period of prolonged, continuous contact with ocular tissue and ocular fluids. Upon hydration, this lens contains enough bulk water content that corneal health is not substantially compromised and wearer comfort is acceptable during a period of prolonged, continuous contact with ocular tissue and ocular fluids.
- a contemplated ophthalmic lens has a water content of at least 20 weight percent, measured gravimetrically or by refractometer, and preferably greater than about 30 weight percent upon full (equilibrium) hydration, up to about 65 weight percent. Usual values are about 35 to about 55 weight percent.
- the polymeric contact lens material comprises a co-polymer of (a) a non-ionic hydrophilic monomer, (b) a hydrophobic (aromatic, aliphatic or mixture) monomer, (c) a tris (siloxy) silyl group- containing monomer, (d) a fluorinated monomer containing about 3 to about 20 fluorine atoms per monomer molecule (polyfluorinated monomer) and (e) a cross-linking agent.
- the weight ratio of the tris (siloxy) silyl group-containing monomer to the non-ionic hydrophilic monomer is about 0.3:1 to about 2:1.
- This lens material has an oxygen permeability of greater than about 60 Dk units, and a water content at equilibrium hydration of about 20 to about 55, and preferably about 35 to about 55 weight percent.
- a polymeric contact lens comprises a co-polymerized (a) non- ionic hydrophilic monomer containing a methacrylamide, an acrylamide, a methacrylate ester or an acrylate ester group,
- the weight ratio of the tris (siloxy) silyl group- containing monomer to the non-ionic hydrophilic monomer is about 0.3:1 to about 2:1.
- This lens exhibits an oxygen transmissibility of about 60 to about 150 Dk units and a water content at equilibrium hydration of about 20 to about 55, and preferably about 35 to about 55 weight percent.
- a polymeric contact lens comprises a co-polymerized (a) a non- ionic hydrophilic monomer containing a methacrylamide, an acrylamide, a methacrylate ester or an acrylate ester group,
- This lens exhibits an oxygen transmissibility of about 45 to about 150 Dk units, preferably greater than 45 Dk units, and more preferably greater than 60 Dk units, and a water content at equilibrium hydration of about 20 to about 55, and preferably about 35 to about 55 weight percent.
- a polymeric contact lens comprises a co-polymerized (a) a non-ionic hydrophilic monomer containing a methacrylamide, an acrylamide, a methacrylate ester or an acrylate ester group,
- a fluorinated monomer containing about 3 to about 20 fluorine atoms per monomer molecule a tris (siloxy) silyl group-containing monomer, (d) a hydrophobic C ⁇ -Cio acrylate or methacrylate monomer and (e) a cross-linking agent.
- the weight ratio of the tris (siloxy) silyl group-containing monomer to the non-ionic hydrophilic monomer is about 0.3:1 to about 2:1.
- This lens exhibits an oxygen transmissibility of greater than 50 Dk units and a water content at equilibrium hydration of about 35 to about 55 weight percent.
- a contemplated contact lens is the co-polymerization product of a monomer mixture comprising (a) a non- ionic hydrophilic monomer, (b) a tris (siloxy) silyl group-containing monomer, (c) a hydrophobic aromatic monomer such as a styrene-containing monomer, (d) a polyfluorinated monomer, a cationic monomer, a hydrophobic non-aromatic monomer or a mixture of two or three of those monomer types and (e) a cross-linking agent.
- a monomer mixture comprising (a) a non- ionic hydrophilic monomer, (b) a tris (siloxy) silyl group-containing monomer, (c) a hydrophobic aromatic monomer such as a styrene-containing monomer, (d) a polyfluorinated monomer, a cationic monomer, a hydrophobic non-aromatic monomer or a mixture
- the monomer mixture includes a weight ratio of tris (siloxy) silyl group- containing monomer to hydrophilic monomer of about 0.3:1 to about 2:1, and a weight ratio of tris (siloxy) silyl group- containing monomer to a single monomer or monomer mixture of (d) of about 1.5:1 to about 20:1; the polyfluorinated monomer, cationic monomer, hydrophobic non-aromatic monomer or mixture of two or three of those monomer types is present up to about 35 weight percent.
- This lens also exhibits an oxygen transmissibility of about 45 to about 150 Dk units and a water content at equilibrium hydration of about 35 to about 55 weight percent .
- a contact lens is formed from the co-polymerization product of a monomer mixture comprising (a) a non-ionic hydrophilic monomer, (b) a cationic monomer, (c) a tris (siloxy) silyl group-containing monomer, (d) a hydrophobic aromatic monomer such as a styrene- containing monomer, and (e) a cross-linking agent.
- the monomer mixture includes a weight ratio of tris (siloxy) silyl group-containing monomer to hydrophilic monomer of about 0.3:1 to about 2:1.
- This lens also exhibits an oxygen transmissibility of about 45 to about 150 Dk units, and preferably greater than 45 Dk units, and a water content at equilibrium hydration of about 35 to about 55 weight percent.
- a contact lens is formed from the co-polymerization product of a monomer mixture comprising (a) a non-ionic hydrophilic monomer, (b) a poly- (dimethylsiloxy) silyl group-containing monomer, (c) a tris (siloxy) silyl group-containing monomer, (d) a hydrophobic monomer, preferably, a hydrophobic aromatic monomer such as a styrene-containing monomer, and (e) a cross-linking agent.
- the monomer mixture includes a weight ratio of tris (siloxy) silyl group-containing monomer to hydrophilic monomer of about 0.3:1 to about 2:1.
- a contemplated lens exhibits a water content on hydration of at least 20 weight percent up to about 55 weight percent, and a Dk value of about 55 to about 150 units.
- a method for improving the water content of a contact lens formed from the polymerization product of a monomer mixture comprising a tris (siloxy) silyl group-containing monomer comprises admixing a polyfluorinated monomer, a cationic monomer, a hydrophobic non-aromatic monomer or a mixture of two or three of those monomer types into the monomer mixture in sufficient amount to increase the water content of the contact lens such that the contact lens has reduced corneal adhesion and is suited for continuous wear for prolonged periods in intimate contact with ocular tissue and ocular fluids.
- the water content increases by at least 15 weight percent of the total weight of the hydrated lens as compared to a similar lens free of the polyfluorinated monomer, cationic monomer, hydrophobic aromatic monomer or mixture thereof .
- a still further embodiment contemplates an extended wear contact lens that comprises a co-polymer of (a) a non- ionic hydrophilic monomer, (b) a tris (siloxy) silyl group- containing monomer, (c) a cationic monomer, (d) a polyfluorinated monomer, a poly- (dimethylsiloxy) silyl monomer, a hydrophobic monomer (aromatic or non-aromatic monomer) or a mixture of two or three of those monomer types and (e) a cross-linking agent is also contemplated.
- This lens exhibits an oxygen transmissibility of about 55 to about 150 Dk units, and a water content at equilibrium hydration of at least 20 weight percent, and preferably about 35 to about 55 weight percent .
- the lens separately binds mucin and lysozyme in vi tro at a ratio by weight of about 1:2 to about 2:1 and in an amount of about 0.75 to about 2.5 ⁇ g/cm 2 , when those proteins are separately present at initial concentrations of 0.46 g/L in aqueous buffers at a pH value of 7.2-7.6.
- Preferred lens bulk water content on complete (equilibrium) hydration is greater than about 20 weight percent. More preferably, the lens has a water content of about 35 to 50 weight percent, based on the total lens weight. Most preferably, a hydrated lens contains about 40 to about 55 weight percent water. A particularly preferred lens water content is greater then 40 weight percent.
- a contemplated lens is a co-polymer of several monomers.
- Table A below, provides exemplary approximate amounts of those monomers that can be present in contemplated lenses, along with preferred amounts when a given monomer is present. Inasmuch as all monomers need not be present in a particular lens, the amount of monomer present in Table A can exceed 100 percent.
- those monomers can be present at about 30 to about 40 weight percent. Preferably, one or more of those monomers is present at up to about 35 weight percent.
- the hydrophilic monomers include, but are not limited to (a) hydroxylated C1-C4 -alkyl acrylates and methacrylates that illustratively include 2-hydroxylethyl methacrylate (HEMA), 2- hydroxylethyl acrylate (2-HEA), glyceryl methacrylate (GMA) , 3-hydroxypropyl methacrylate, 3-hydroxypropyl acrylate, 4- hydroxybutyl methacrylate, 4-hydroxybutyl acrylate, N- vinylpyrrolidone (NVP) , ⁇ -methylglucoside- 6 -methacrylate, polyhydroxy sucryl alkyl acrylates, N- (2-hydroxypropyl) methacrylamide , N-methylmethacrylamide , poly (ethyleneglycol) (n) monomethacrylate, (b) poly(C2-C3 alkylene ether) (n) mono C1-C4 alkyl ether acrylates or methacrylates
- HEMA 2-hydroxyleth
- a contemplated hydrophilic monomer is non-ionic under conditions of intended use, e.g., the monomer does not exhibit a charge in water at pH values of 6-8, and particularly at pH 7.2-7.4.
- anionic monomers that exhibit a negative charge at those pH values are excluded from this class of monomers, as are cationic monomers that exhibit a positive charge at those pH values.
- the hydrophilic monomers are non- ionic and contain an acrylamide, methacrylamide, an acrylate ester or a methacrylate ester group.
- These monomers are exemplified by unsubstituted, mono- and di-substituted C1-C4- alkyl acrylamide and methacrylamide, and hydroxylated C1-C4- alkyl acrylate and methacrylate esters.
- non-ionic monomers that contain an acrylamide, methacrylamide, and acrylate or methacrylate ester group are selected from the group consisting of HEMA, 2-HEA, GMA, DHPA, 3-hydroxypropyl methacrylate, 3-hydroxypropyl acrylate, 4- hydroxybutyl methacrylate, 4-hydroxybutyl acrylate, DMA and DMMA.
- N,N-Dimethylacrylamide is most preferred.
- Another group of co-monomers contains a vinyl group that is preferably an acrylate or methacrylate, and tris (trimethylsiloxy) silyl group, and has a molecular weight of about 6000 grams per mole or less.
- Suitable monomers include methacryloxypropyltris (trimethylsiloxy) silane (TI) , methacryloxypropyltris (trimethylsiloxydimethylsiloxy) silane (T2) , N- [tris (trimethylsiloxy) silylpropyl] methacrylamide (TSMAA) , N- [tris- (trimethylsiloxy) silylpropyl] acrylamide (TSAA) , N- [tris (trimethylsiloxy) silylpropyl] methacryloxyethyl carbamate (TSMC) , N- [tris (dimethylpropylsiloxy) - silylpropyl] methacrylamide, N- [tris- (di
- the weight ratio of tris (trimethylsiloxy) -silyl group-containing monomer to hydrophilic monomer is typically about 0.3:1 to about 2:1, and is more preferably about 0.6:1 to about 2:1. That ratio is most preferably about 0.7:1 to about 1.4:1, and is often expressed herein as a weight ratio of particularly preferred tris (trimethylsiloxy) silyl group- containing monomer TI to particularly preferred hydrophilic monomer DMA.
- the invention is usually carried out with a hydrophobic aromatic or aliphatic monomer or a mixture of those monomers that is copolymerizable with the selected hydrophilic monomer and tris (trimethylsiloxy) silyl group- containing monomer.
- hydrophobic aromatic monomers include styrene, 2 , 4 , 6-trimethylstyrene (TMS) , t-butyl styrene (TBS) and 2-vinylnaphthalene . Of these monomers, a styrene- containing monomer is preferred.
- a styrene-containing monomer is defined herein to be a monomer that contains a vinyl group bonded directly to a phenyl group in which the phenyl group can be substituted by other than a fused ring, e.g., as above with one to three C ⁇ -Cg alkyl groups.
- C5H5] is a particularly preferred styrene-containing monomer.
- Hydrophobic aliphatic (non-aromatic) monomers include C]_-C ⁇ o aliphatic esters of acrylic acid or methacrylic acid.
- Exemplary monomers include methyl methacrylate, ethyl methacrylate, methyl acrylate, propyl methacrylate, iso-propyl methacrylate (iso-propyl MA) , propyl acrylate, iso-propyl acrylate, butyl methacrylate, hexyl acrylate, octyl methacrylate, decyl methacrylate and the like.
- methacrylates are preferred over acrylates, with shorter ester chains (C1-C3) being preferred over longer chains .
- the hydrophilic monomer and tris- (trimethylsiloxy) silyl group-containing monomer are also usually co-polymerized with a fluorinated monomer containing 3 to about 20 fluorine atoms per monomer molecule that itself contains 4 to about 20 carbon atoms, and preferably contains about 6 to about 15 carbon atoms, sometimes also referred to a polyfluorinated monomer.
- a polyfluorinated monomer has a molecular weight of less than about 700 grams per mole.
- Preferred fluorinated monomers include 2-(N-ethyl- perfluorooctanesulfonamido) -ethylacrylate (FX-13), 2-(N-ethyl- perfluoro-octanesulfonamido) ethyl methacrylate (FX-14), 2,2,2- trifluoroethyl methacrylate (TEM) , IH, IH, 7H-dodecafluoroheptyl acrylate (DFHA) , hexafluoroisopropyl acrylate, 1H,1H,2H,2H- heptadecafluorodecyl acrylate, pentafluorostyrene (PFS) , trifluoromethylstyrene, pentafluoroethyl acrylate, pentafluoroethyl methacrylate, hexafluoroisopropyl acrylate, hexa
- a preferred fluorinated monomer containing 3 to about 20 fluorine atoms per monomer molecule is an amide or ester of acrylic acid or methacrylic acid.
- Particularly preferred fluorinated monomers containing 3 to about 20 fluorine atoms per monomer molecule are FX-13, FX-14 and 1H,1H,2H,2H- heptadecafluorodecyl acrylate that contain 13 or 14 carbon atoms and PFS and HFIPMA that contain six to eight carbon atoms.
- the most preferred of these monomers are FX-13 and FX- 14 that are sulfonamido ethyl esters of acrylic acid or methacrylic acid.
- Cationic monomers are also useful in a contemplated ophthalmic lens.
- Suitable cationic monomer materials have a molecular weight of about 600 grams per mole or less, and include a quaternary ammonium group or a tertiary amine group that can be protonated at a pH value of about 7.2-7.4 (physiological pH values) .
- Illustrative monomers include the tertiary Cj .
- -C]_Q -alkyl C2-C3-alkanol
- benzyl aminoethyl or N-morpholinoethyl esters of acrylates and methacrylates such as 2-dimethylaminoethyl methacrylate (DMEAM) , 2-N- morpholinoethyl methacrylate (MEM), N,N-diethanolaminoethyl methacrylate, N,N-dimethoxyethylaminoethyl methacrylate, vinyl amine, aminostyrene, 2 -vinyl pyridine, 4 -vinyl pyridine, N-(2- vinyloxyethyl) piperidine and quaternary ammonium compounds such as 3-trimethylammonium-2-hydroxypropyl methacrylate chloride (TMAHPM) , 2-trimethylammoniumethyl methacrylic hydroxide, 2-trimethylammoniumethyl acrylic hydroxide, 2- trimethyl-ammoniummethyl
- a cationic monomer that is an ester of acrylic or methacrylic acid is preferred.
- a cationic monomer is typically present at about 15 to about 30, and more preferably about 20 to about 25, weight percent. MEM and DMAEM are particularly preferred cationic monomer.
- Some aspects of the invention contemplate the co- polymerization of (a) a non- ionic hydrophilic monomer, (b) a tris (siloxy) silyl group-containing monomer, (c) a hydrophobic aromatic monomer such as a styrene-containing monomer, (d) a polyfluorinated monomer, a cationic monomer, a hydrophobic non-aromatic monomer or a mixture of two or three of those monomer types and (e) a cross-linking agent.
- Polyfluorinated, cationic and hydrophobic non-aromatic (aliphatic) monomer types are as discussed before.
- siloxy monomers are those that contain poly (dimethylsiloxy) silyl -containing group and are typically polysiloxane vinylic monomers that are preferably an ester or amide of acrylic acid or methacrylic acid.
- Particularly preferred monomers containing a poly (dimethylsiloxy) silyl group are mono-acrylate, methacrylate, acrylamide or methacrylamide compounds linked to a dimethyl silicone portion such as MD9 and MD63 ; i.e., monomers having molecular weights of about 1000 to about 5000.
- a polymerized cross-linker is also usually present in a contemplated ophthalmic lens.
- Suitable cross-linkers, or cross-linking agents include ethyleneglycol dimethacrylate (EGDMA) , 1, 6-hexanediol diacrylate (HDODA) , 1 , 4-butanediol diacrylate (BDODA) , trimethylolpropane triacrylate (TMPTA) , tripropyleneglycol diacrylate (TRPGDA) , diethyleneglycol diacrylate (DEGDA) , tetraethyleneglycol diacrylate (TEGDA) , pentaerythritol triacrylate, pentaerythritol tetraacrylate and the like.
- EGDMA is particularly preferred.
- a co-polymerization containing the desired monomer and cross-linker when present, also typically contains an of an activator or initiator such as (2 , 2-azobisisobutyronitrile (AIBN; V-64), t-butyl hydroperoxide, di-t-butyl peroxide and the like as are well known.
- an activator or initiator such as (2 , 2-azobisisobutyronitrile (AIBN; V-64), t-butyl hydroperoxide, di-t-butyl peroxide and the like as are well known.
- a sensitizer for UV polymerization can also be present.
- Co-polymerization by ionizing radiation usually does not require an initiator.
- combinations of polymerization techniques can be used to initiate and propagate the free-radical polymerization chain reaction that is used herein.
- the oxygen permeability of the polymer and lens is preferably at least 45 barrers, more preferably at least 50 barrers (greater than 50 barrers) , and most preferably at least 60 barrers (greater than 60 barrers) .
- the lens center thickness is typically more than about 50 microns, preferably about 50 to about 200 microns, more preferably about 50 to about 150 microns, even more preferably about 50 to about 120 microns, and most preferably about 60 to about 100 microns.
- the oxygen transmissibility of a contemplated lens from the outer surface to the inner surface is sufficient to prevent any substantial corneal swelling during prolonged wear.
- U.S. Patent No. 5,760,100 reports it to be known that the cornea swells approximately 3 percent to 4 percent during overnight periods of sleep as a result of oxygen deprivation, and that wearing a typical contact lens, such as ACUVUE ® (Johnson & Johnson) , for a period of about 8 hours (overnight wear) can cause corneal swelling of about 11%.
- a contemplated ophthalmic lens is usually prepared by co-polymerization of constituent monomers neat, in the absence of a diluent or non-co-polymerizing solvent.
- the molded polymerization of such a composition is often referred to as dry casting. It is noted, however, that the co- polymerization can also be carried out in the presence of a non-co-polymerizing solvent. Such a molded polymerization is often referred to as wet casting.
- a non-co-polymerizing solvent for wet casting ophthalmic lenses is miscible in the monomer mixture and is readily removable from the polymerized lens.
- Exemplary solvent removal methods include evaporation, washing in water or saline or the like.
- An exemplary solvent is preferably a water-miscible C1-C4 monohydric alcohol solvent such as methanol, ethanol, propanol, iso-propanol , sec-butanol and t- butanol , although other solvents such as acetone, 2-butanone, tetrahydrofuran, benzene and toluene are also contemplated.
- a wet casting solvent can be present in an amount less than that lowers the provides a stress at break value to 0.03 N/mm 2 .
- the solvent is present at a concentration of less than about 20 weight percent of the total copolymerization composition, and more preferably at about 15 weight percent or less.
- wet casting i.e., co-polymerizing lens-forming monomers in the presence of a non-co-polymerizable solvent, can increase the oxygen transmissibility of a formed lens by about 5 to about 20 percent compared to a dry cast lens prepared from the same monomers in the same proportions.
- the water content of a lens is the weight percent of water based on the total weight of the hydrated lens.
- the measurement of this water content is difficult because the removal of adhered surface droplets, without affecting the bulk lens water content, is not trivial.
- water can evaporate from the lens surface quickly, thereby lowering the water content from the equilibrium level. Accordingly, a discussion of the bulk water content of a lens warrants a discussion of the measurement technique used for that determination.
- the preferred bulk water content of the hydrated lens is a function of the lens material properties.
- the material properties are dependent on the pre-polymerization macromers and monomers and polymerization conditions.
- the preferred water content for a lens including a fluorine- containing siloxane material can be different from that of a lens including a non-fluorine-siloxane-containing material. Accordingly, although general ranges for bulk water content are offered for a better understanding of the invention, the invention is not generally limited to specific bulk water contents .
- the Bulk Technique procedure is as follows.
- the lens is thoroughly hydrated in a physiological saline solution (0.9 percent sodium chloride), such that the water in the lens is in equilibrium with the surrounding water.
- a physiological saline solution 0.9 percent sodium chloride
- the lens is gently blotted between two lint-free blotting cloths to remove surface moisture.
- the lens is quickly placed on an aluminum weighing pan and the first wet weight, W]_, is measured.
- the aluminum pan with lens is placed in an oven at 36° C for a period of at least 24 hours. After heat treating, the pan with lens is removed, placed in a desiccator, and permitted to cool to room temperature (about 22° C) .
- the pan with lens is weighed again to determine the dry weight, W ⁇ .
- the lens is re-equilibrated in physiological saline solution and a second wet weight 2 is determined thereon.
- the wet weights (W ⁇ and W2) are averaged to yield an average wet weight, W w .
- the bulk water content is determined by the following equation:
- Refractometer Technique An additional method of measuring the water content of a lens formed in accordance with the present invention, referred to herein as the "Refractometer Technique", utilizes a refractometer such as an AtagoTM Refractometer and is as follows :
- a stoppered glass container is one-half filled with salt (sodium chloride) , deionized water is preheated to 40- 45°C and is added until the container is three quarters full.
- a Teflon-coated stopper is used to seal the container. The container is shaken for 2 minutes, then stirred for 30-60 minutes. The supernatant of this solution is used to calibrate the refractometer ' s scale. If all of the salt is dissolved in the solution (that is, there is no salt remaining at the bottom of the container) , additional salt is added until there remains a residue that will not dissolve. The mixture is cooled to room temperature.
- the scale is calibrated at room temperature.
- the daylight plate is opened, and a few drops of the saturated salt solution are placed on the prism surface using a disposable pipet .
- the daylight plate is closed.
- the solution should cover the whole prism surface when the daylight plate is closed.
- the boundary between the upper and lower parts of the field are aligned with the "S" marking on the scale.
- the lens is lightly dabbed with a soft lint-free tissue to remove excess surface moisture.
- the daylight plate is opened and the lens is placed on the center prism with the convex surface of the lens facing downward. The central portion of the lens is in opposition with the prism surface.
- the daylight plate is gently closed with the application of light pressure to the top of the plate so that the lens is between the daylight plate and prism.
- the eyepiece is focused so that the scale can be clearly observed.
- the upper portion of the field of view should appear blue, and the lower portion white. The position of the boundary between the upper and lower parts of the field indicates the water content in weight percent of the lens, which is read off the vertical scale.
- water permeability is one important feature for an extended-wear lens. Siloxane- containing materials tend to adhere strongly to the eye, thereby stopping on-eye movement via forces exerted by water being squeezed out of the lens. The ability to pass water through the lens is thought to permit a polymeric lens to relax and continue to move on the eye. The water permeability of the lens is also believed important in replenishing lens water content once pressure is removed. Indeed, the lack of sufficient ophthalmic fluids under the lens may contribute to adhesion of the lens to the cornea. Thus, water permeability is thought to be one predictor of on-eye movement .
- Lens diameters were determined using a machinist's microscope, whereas center thickness was measured using a RehderTM Electronic Thickness Gauge (Model ET-3) .
- Lens power was determined on a TopconTM LM-P5 Digital Lensmeter. Water content was measured using an AtagoTM refractometer according to the "Refractometer Technique" described above. Oxygen permeability measurements were performed by Mocon Corp. (Minneapolis, Minnesota) according to their OptiPermTM technology, as described in U.S. Patent No. 5,817,924, whose disclosures are incorporated by reference.
- the analyzer was calibrated using standard contact lens materials. Methods and calculations used to perform Dk measurements on the soft contact lenses are as discussed herein below. Fresh borate-buffered saline, pH 7.48, was made prior to use. All water content numbers were measured using the AtagoTM hand refractometer (Model CL-1, Japan), with contents lower than 35 percent being estimated.
- the contact lens was mounted in a lens holder over the oxygen sensor. Any air bubbles were removed, and the apparatus was immersed in physiological saline solution kept at a temperature of 37°C with a circulating water bath. After an equilibration time, the oxygen level with the lens on the sensor was compared to the level without the lens in place.
- the corresponding oxygen permeability can be calculated from the following formula:
- L lens sample thickness (mm) ;
- K a constant determined from reference lenses (Dk) ; typically between 9- 14 Dk units.
- a lens is placed in the appropriate protein solution (normally lysozyme concentration of 0.46 g/L to simulate physiological conditions) for the desired length of time.
- the lens is rinsed, blotted, and placed on the ATR crystal.
- the presence of protein can be observed by examination of the Amide I and II peaks.
- the amount of protein can be determined by comparing the absorbance at these wavelengths with a calibration curve. This analysis method can determine the amount of protein deposited on a contact lens exposed to a protein solution or worn.
- ATR accessory (#091-0507B, Bio-Rad ® )
- Buffered normal saline solution should be made prior to experimentation. Briefly, 0.25 mL of sodium bicarbonate buffer is added to 1.5 L of sodium chloride irrigation buffer using a sterile 10 mL injection syringe. The solution has a pH value between 7.6-7.2. Lysozyme dilution is performed using glass 100 mL volumetric flask.
- the ATR accessory is placed in the IR light path, as directed by the ATR accessory manual .
- the interferogram center burst verifies that the crystal is aligned in the IR beam (-0.85 V in amplitude) .
- the IR parameters should be as follows: open aperture, 5 kHz scan speed, and 1.5 kHz low pass filter.
- the ZnSe crystal is cleaned by brushing the surface with a Kimwipe ® -wrapped cotton swab soaked with 1-2 drops of methanol . No methanol signal should be evident on the crystal after a few seconds of air drying. A background single-beam spectrum is obtained by signal -averaging 32 scans.
- Control spectra of each contact lens material are obtained from fresh lenses from production.
- Each lens is removed from its storage solution using polypropylene tweezers and placed on a Kimwipe ® .
- Excess buffer solution is removed by blotting the lens with another Kimwipe ® ; any visible buffer makes subtraction of the contact lens substrate more difficult.
- the lens is placed on the ZeSe crystal and compressed using the ATR sample holder to increase absorbance.
- This area is calculated to be approximately 1.215 cm 2 for a 14.5 mm contact lens on the 9 mm wide crystal. Subsequent studied lenses are compressed to make the absorbance peak at
- a lysozyme calibration curve is constructed by placing known concentrations of lysozyme solution on the ZnSe crystal using a 10 ⁇ L Eppendorf pipette when analyzing a new contact lens material. Approximately 10 drops of the solution are spread over the crystal to ensure monolayer protein coverage. A drying time of 15 minutes is used, based upon visible and IR observations. A spectrum of each protein concentration is made by signal averaging 32 scans.
- the Amide II peak height at 1,540 cm “1 is used to construct a calibration curve. This particular peak has less error from overlapping water bands compared with the Amide I peak.
- a least square fit linear regression model provides an equation relating deposited protein to absorbance (absorbance units; a.u.) of the Amide II peak:
- Each lens to be assayed is placed within a vial containing the protein solution of interest (typically 0.46 g/L lysozyme in buffer solution is used) .
- the sample vials are sealed and placed in a water bath at 37° C for the desired duration.
- the lenses are removed from the bottle, blotted dry with Kimwipes ® , and placed on the ATR-FTIR for analysis.
- the spectrum is adjusted with the sample holder to make the 1703 cm "1 peak height the same as the control lens (see above) .
- the control contact lens spectrum is used to subtract the absorbance due to the substrate. This results in a spectrum of the residual proteins deposited on the lens.
- the protein concentration deposited on the surface of the lens now can be determined from the calibration curve.
- a lens made in accordance with the present invention typically has a significantly larger water flow rate than the prior art lenses made from silicon- containing monomers.
- the water flux is greater than about 0.40xl0 -5 g/cm 2 -sec. More preferably, the water flux is greater than about 0.50x10 " ⁇ g/cm 2 -sec.
- a contemplated lens can exhibit a higher tear exchange rate and is less likely to adhere to human eyes, although a surface treatment can still be required to provide a desired amount of movement of a lens on the eye.
- a reliable method to measure water flow is described as follows:
- An experimental apparatus 1 is shown in cross- section in Fig. 1.
- This device is filled with a buffer solution 3 (11.3 mM sodium chloride, 8.1 mM boric acid, 0.3 mM sodium borate, pH 7.2-7.5; hereinafter borate-buffered saline) and a contact lens 5 is placed on top.
- a cover 7 is placed over the lens with an o-ring 9 pressing the lens against the lens holder.
- a 6.3 -mm hole 11 in the cover permits water to flow from the lens holder reservoir through the lens and out the cover.
- the lens cover has a matching hole 13 for water passage, and is fixed in place with a screw ring 15. Excess buffer solution is removed with an absorbent wipe.
- the entire water flow apparatus is placed on an AE200 Mettler ® balance.
- the balance is enclosed in a glove bag (Aldrich AtmosBag ® , Zll, 282-8) , which is sealed rapidly with a quick closing glove bag clamp (I 2 R, AC-24) .
- Air is passed through a bubbler into the bag.
- the bubbler is filled with a glycerol/water mix (69.4% w/w glycerol) to bring the relative humidity inside the bag to about 50% after 5-10 minutes.
- the relative humidity and temperature are monitored using a Mannix ® model LAM 880D pocket thermo-hygrometer .
- the reading on the Mettler ® balance is monitored by a data acquisition program.
- One embodiment of the invention uses a cationic monomer in the lens polymer material and provides a prolonged wear lens. This embodiment involves the attractive ionic forces between a cationic polymer and an anionic mucin layer of the tear film to adhere mucin to the lens.
- a cationic-modified base lens can prevent corneal adhesion through attraction of the tear mucin layer.
- Silicones have low surface energy and can repel the mucinous layer that makes up the foundation of the ocular tear film. This disruption of the tear film may be a reason for adherence of a contact lens to the cornea even with lenses having high water flow.
- a lens with a formal positive charge at physiologic pH values e.g., about 7.2-7.4 can electrostatically attract and deposit the negatively-charged mucin layer.
- a contemplated prolonged wear contact lens comprises a co-polymer of (a) a non-ionic hydrophilic monomer, (b) a tris (siloxy) silyl group-containing monomer, (c) a cationic monomer, (d) a polyfluorinated monomer, a poly- (dimethylsiloxy) silyl monomer, a hydrophobic monomer (aromatic or non-aromatic monomer) or a mixture of two or three of those monomer types and (e) a cross-linking agent is also contemplated.
- This lens exhibits an oxygen transmissibility of about 45 to about 150 Dk units, and a water content at equilibrium hydration of about 35 to about 55 weight percent.
- the lens separately binds mucin and lysozyme in vi tro at a ratio by weight of about 1:2 to about 2:1 and in an amount of about 0.75 to about 2.5 ⁇ g/cm 2 , when those proteins are separately present at initial concentrations of 0.46 g/L in aqueous buffers at a pH value of 7.2-7.6.
- the lens binds both lysozyme and mucin in similar amounts (about 1:2 to about 2:1 by weight), and preferably in about the same amount (about 1:1) using the assay discussed elsewhere herein in which each protein is initially present at 0.46 g/L in an aqueous buffer having a pH value of about 7.2-7.6.
- the particular buffer is not thought to be particularly important. However, it is preferred to use a sodium bicarbonate buffer.
- contemplated contact lenses that include a cationic or hydrophobic monomer provide high water content and oxygen permeability (Dk value) , as compared to lenses known in the art .
- M2K2 is 1 , 3-bis (3 -methacryloxypropyl) tetrakis-
- TMS 6-Trimethylstyrene
- DMA dimethylacrylamide
- MCM Monomer-Polymer & Dajac Labs (Feasterville, PA)
- MMA methyl methacrylate
- styrene and 4-t-butylstyrene purchased from Aldrich Chemical Co., (Milwaukee, WI) .
- the various samples were prepared for dry casting, in which 400 ⁇ L of the monomer solution were placed in the female part of a casting cup, the male part placed in the female part, and the excess was evacuated off. After polymerization, the lenses were removed and then hydrated overnight (about eighteen hours) in borate-buffered saline (pH 7.48) before being transferred to contact lens (CL) vials containing packaging solution for storage.
- CL contact lens
- FreshLookTM casting cup molds were used from production (-3.00 or -0.50 D/14.5 mm dia/8.25 thick). Filling was done with an Eppendorf combitip plus 5 mL tip set at delivering 300-400 ⁇ L of monomer solution. Closing was done with a laboratory filler/closer (in hood) . The DespatchTM (model LN01-42-2, Minneapolis, MN) oven was used for thermal polymerization.
- the monomers are mixed in the order of their mass, from lowest to highest. The mixtures were stirred sufficiently to form a homogeneous solution.
- Casting cups normally used in the art were prepared according to known techniques including corona activation of the male part.
- the reaction mixture previously prepared was placed in the female part of the casting cups.
- the casting cups were closed and placed in a reaction chamber.
- the atmosphere is removed by vacuum and replaced with an inert atmosphere such as N 2 .
- the monomer mixture was subjected to UV energy sufficient to cause polymerization. Suitable UV energy to cause polymerization is about 0.7 mW/cm 2 to about 3 mW/cm 2 for between 1 to 6 hours, preferably for 2 hours.
- An ophthalmic lens according to this procedure is formed following the mixing procedure presented in Procedure A except that final polymerization is accomplished through thermal energy initiation of the free radical chain reaction.
- Any temperature range suitable to cause polymerization of the mixture of monomers is acceptable. Suitable temperature ranges include between about 60° C to 150° C and preferably between 80° C and 120° C for a period of time to permit the desired polymerization to occur. Suitable periods of time for accomplishing the desired polymerization are about 0.25 to about 4 hours, preferably about 2 to about 4 hours, and most preferably about 4 hours.
- the ambient atmosphere in the oven can be partially or completely replaced with an inert gas such as nitrogen or argon.
- UV initiated polymerization is also caused to cure under thermal polymerization conditions, and vice versa.
- one technique can be used to post cure lenses prepared by the other technique.
- the monomer-filled and closed casting cups are placed in a steel block autoclave at a predetermined minimum temperature such as about 110°C.
- the monomer mixture is thermally polymerized for a time period of about ten to about fifteen minutes at a temperature of about 110 to about 140°C and more preferably at about 120 to about 135°C , after which time the casting cups are removed, opened, the lenses removed and hydrated as discussed before.
- a similar high temperature fast polymerization can also be carried out in a DespatchTM oven (Model LN01-42-2, Minneapolis, MN) .
- the 0 2 Dk values are from figures published by the respective lens manufacturer.
- the brass metal has the lowest water loss rate and should provide the error observed from water leakage around the sample holder. Although low, this water leakage rate is measurable. Possibly, the brass does not conform well to the surface of the lens holder, permitting a larger amount of water to seep around the material than with the more compliant contact lenses.
- the SilsoftTM lens has a slightly higher water flow than the brass, possibly because of the higher water vapor diffusion rate through the flexible silicone matrix. Again, only water vapor can penetrate the lens, so SilsoftTM shows a low water flow rate compared to the hydrogels. This low water flow rate can cause the high degree of corneal adhesion seen with this material, although repulsion of the mucin layer of the tear film may also account for the observed corneal adhesion.
- the original base lens, modified base lens, ClearviewTM, FreshLookTM, and GentleTouchTM lenses exhibited water flow loss rates in order of their water contents.
- the GentleTouchTM lens had a water loss rate similar to that of the buffer (no lens) control sample.
- the GentleTouchTM matrix does not impede the flow of water across this material .
- Examples 0-17 Contact Lenses Table 2 shows the composition of a base lens formulation. Unless noted otherwise, all formulation/composition units are in grams-mass.
- This lens formulation includes a silicone-containing monomer, TI, a hydrophilic monomer, DMA, small amounts of a styrene- containing monomer, TMS, and a cross-linker EGDMA. But this formulation does not contain a fluorinated hydrophobic monomer. Although this lens formulation exhibits relatively adequate levels of oxygen permeability, it has a low water content measured as a weight percent of the total weight of the hydrated lens. Also, this lens exhibits adhesion to a human cornea that makes it unsuited for prolonged wear.
- Examples 1, 2 and 3 demonstrate that the incorporation of a fluorinated monomer, containing 3 to about 20 fluorine atoms per monomer molecule unexpectedly increases the water content of the lens without significant reduction in oxygen permeability. These lenses are believed to not adhere to the human cornea and, thus, are appropriate for prolonged wear.
- Table 3 shows the results of varying the amounts of silicone-containing monomer, TI , hydrophilic monomer, DMA, and fluorinated hydrophobic monomer, FX-13 in the lens formulation. Giving considerable weight to the optical clarity of the lens, as well as resiliency to deformation, examples Nos. 4 and 15 (duplicates) appear to have more desirable combined characteristics along with water content and oxygen permeability.
- TBS t-Butylstyrene
- PFS Pentafluorostyrene
- Examples 26-31 Effect of T1:DMA Ratio on Base Lens Formulations
- a study was conducted to examine the effect of the ratio of TI monomer to DMA monomer in the absence of a polyfluorinated monomer as in the "base” formulation of Table 2.
- the lens formulations are shown in Table 7, below, wherein “Ex.” means Example.
- the effects of altering that ratio on oxygen permeability and water content are shown in Table 8, thereafter.
- TMS 2,4,6- trimethylstyrene
- Table 3 The formulations for those lenses and their water contents and oxygen permeabilities are shown in Table 9, below. As will be seen, each of the lenses so prepared exhibited excellent properties.
- Aromatic-Modified Lenses Additional lenses were prepared using styrene in place of trimethylstyrene (TMS) in the formulation of Example 4, in which FX-13 was present at about 9.4 percent and the TlrDMA ratio was about 1.
- TMS trimethylstyrene
- the formulation used is illustrated below in Table 10, and is referred to elsewhere as "S-base” .
- a formulation was also prepared that contained about the same amount of styrene, as well as about 3.6 weight percent MD9 monomer as a replacement for an equal amount of DMA, that is referred to as MD9-S-base.
- Lenses so prepared and commercially available lenses were soaked in 0.46 g/L lysozyme solution and analyzed using infrared spectroscopy to determine the amount of protein adsorbed onto a lens.
- the amide II bands were measured and converted to protein concentration by a calibration curve. The assay procedures discussed previously, and results of these studies are discussed and shown below.
- the protein concentrations are as follows:
- DS3 DuraSoftTM 3 commercially available lens.
- the S-base and MD9-S-base lenses seemed to adsorb about as much lysozyme as the CSl/ClarityTM, DS2 or GentleTouchTM lenses, within the standard deviation of the measurement. They adsorbed a significantly less amount of protein than DS3 lenses.
- the procedure described before utilizes attenuated total reflectance (ATR) and provides an in vi tro method for estimating the amount of protein deposited onto each contact lens .
- ATR attenuated total reflectance
- Base lens is that of Table 2, Example 0; Cationic- modified is the lens of Example 25, Table 6.
- mucin binds to the base lens at a very low level (comparable to lysozyme binding to a CSI Lens) , and that mucin binds about 5.3 times more to the cationic modified base lens versus the base lens itself.
- the cationic-modified base lens does not exhibit corneal adhesion by binding the mucin, which makes up the base layer of the tear film.
- This mucin layer can improve ocular movement and on eye wettability.
- Example 36 Co-Polymerized Silicone Monomer Incorporation in Styrene- containing Lenses
- silicone and siloxanyl (siloxy-containing) monomers were examined for use in lenses. A chart and corresponding structure for these monomers was shown previously. Silicone methacrylates were added (1-35 weight percent) to the styrene-containing base formulation (shown in Table 12, below) and polymerized using Procedure C.
- the M2D65 was soluble only to about 1 percent, limiting the range for this monomer mixture.
- the M2K2 and M2D2 lenses made clear, albeit non-compliant (i.e. RGP-like stiffness) lenses, especially at high loading levels.
- MD9 exhibited high solubility and made clear lenses, even at 38 weight percent loading.
- Typical silicone monomer contents were about 1 to about 6 weight percent .
- the TI seems more efficient in transporting oxygen than the short methacrylsilicone monomers.
- the tri (siloxy) silyl group from the TI monomer has a larger free volume and more conformational freedom than the dimethylsiloxy group from the methacrylsilicones.
- Other monomers can be used in place of TI, such as vinyl-tris (trimethylsiloxy) silane, vinyl-tris (dimethysiloxy) silane, allyl tris (trimethylsiloxy) silane, or (3-acryloxypropyl) tris (trimethylsiloxy) silane .
- Example 37 Effect of Altered Initiator (V-64) and Cross-linker (EGDMA) Concentrations in Styrene-containing Lenses
- Produced lenses were all clear, but some showed warpage, surface defects, and edge defects. Most showed a good deal of flash, possibly indicating a better evacuation is needed or less monomer should be used. Particulate was observed, possibly indicating that a clean room environment or monomer filtration might be needed for final evaluation.
- Example 39 Lens Preparation Using Aliphatic Hydrophobic Monomers In Place of Aromatic Hydrophobic Monomers
- a series of lenses was prepared from similar compositions that contained a monohydric alcohol as solvent. All of the lenses contained MD9 at about 1 percent of the polymerizable monomers. One pair differed only in containing about 15 weight percent ethanol versus no solvent, whereas the third group of lenses additionally contained the cationic monomer, MEM.
- the lenses were polymerized as before, and were cured in an oven at about 90°C under nitrogen gas for about 3 hours after polymerization to remove the solvent. The compositions of those lenses are shown below in Table 16.
- Lenses were prepared to contain about 21 or about 42 weight percent DMAEM.
- the lenses were prepared using the formulations shown in Table 18. Usual curing at 120°C for ten minutes was inadequate to obtain a full cure, although a cure time of fifteen minutes provided a good cure for the 21 percent DMAEM lenses. Even forty minutes of cure time did not work for the 42 percent DMAEM lenses, and no more was done with those lenses.
- the lenses containing about 21 percent DMAEM (Example 40) were found to contain 48.0% water after hydration and exhibited oxygen permeability values of 61.0 ⁇ 1.2 Dk units.
- Fluorine-Containing Monomers A series of lenses was prepared containing fluorine- containing monomers other than the preferred FX-13. Compositions and properties of some of those lenses are shown below in Table 20.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- General Physics & Mathematics (AREA)
- Eyeglasses (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Auxiliary Devices For And Details Of Packaging Control (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Tumbler Switches (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Casting Or Compression Moulding Of Plastics Or The Like (AREA)
Abstract
Description
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08152715.2A EP1927882B1 (en) | 1999-12-10 | 2000-12-07 | Contact lens |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17016299P | 1999-12-10 | 1999-12-10 | |
| US170162P | 1999-12-10 | ||
| US09/731,331 US6649722B2 (en) | 1999-12-10 | 2000-12-06 | Contact lens |
| US731331 | 2000-12-06 | ||
| PCT/US2000/033237 WO2001042846A1 (en) | 1999-12-10 | 2000-12-07 | Contact lens |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP08152715.2A Division EP1927882B1 (en) | 1999-12-10 | 2000-12-07 | Contact lens |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EP1236068A1 true EP1236068A1 (en) | 2002-09-04 |
| EP1236068A4 EP1236068A4 (en) | 2007-03-28 |
| EP1236068B1 EP1236068B1 (en) | 2008-08-27 |
Family
ID=26865777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP00982514A Expired - Lifetime EP1236068B1 (en) | 1999-12-10 | 2000-12-07 | Contact lens |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6649722B2 (en) |
| EP (1) | EP1236068B1 (en) |
| JP (2) | JP4712265B2 (en) |
| AT (1) | ATE406594T1 (en) |
| AU (1) | AU1953601A (en) |
| CA (1) | CA2392298A1 (en) |
| DE (1) | DE60040090D1 (en) |
| NO (1) | NO20022628L (en) |
| WO (1) | WO2001042846A1 (en) |
Families Citing this family (106)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7038219B2 (en) * | 1996-05-22 | 2006-05-02 | Purepulse Technologies, Inc. | Sterilization of packages and their contents using light |
| US6822016B2 (en) | 2001-09-10 | 2004-11-23 | Johnson & Johnson Vision Care, Inc. | Biomedical devices containing internal wetting agents |
| US7461937B2 (en) * | 2001-09-10 | 2008-12-09 | Johnson & Johnson Vision Care, Inc. | Soft contact lenses displaying superior on-eye comfort |
| US20070043140A1 (en) * | 1998-03-02 | 2007-02-22 | Lorenz Kathrine O | Method for the mitigation of symptoms of contact lens related dry eye |
| US7052131B2 (en) * | 2001-09-10 | 2006-05-30 | J&J Vision Care, Inc. | Biomedical devices containing internal wetting agents |
| EP1173790A2 (en) | 1999-03-01 | 2002-01-23 | Boston Innovative Optics, Inc. | System and method for increasing the depth of focus of the human eye |
| US6880932B2 (en) * | 1999-11-01 | 2005-04-19 | Praful Doshi | Tinted lenses and methods of manufacture |
| US7048375B2 (en) * | 1999-11-01 | 2006-05-23 | Praful Doshi | Tinted lenses and methods of manufacture |
| US7267846B2 (en) * | 1999-11-01 | 2007-09-11 | Praful Doshi | Tinted lenses and methods of manufacture |
| ATE315795T1 (en) | 1999-11-01 | 2006-02-15 | Praful Doshi | TINTED PLASTIC CONTACT LENS AND METHOD FOR THE PRODUCTION THEREOF |
| US6649722B2 (en) * | 1999-12-10 | 2003-11-18 | Novartis Ag | Contact lens |
| JP2001201723A (en) * | 2000-01-18 | 2001-07-27 | Asahi Kasei Aimii Kk | Soft contact lens for continuous wearing |
| US7815944B2 (en) * | 2001-06-20 | 2010-10-19 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity |
| US6891010B2 (en) * | 2001-10-29 | 2005-05-10 | Bausch & Lomb Incorporated | Silicone hydrogels based on vinyl carbonate endcapped fluorinated side chain polysiloxanes |
| BR0307827A (en) * | 2002-02-15 | 2005-03-15 | Zms Llc | Polymerization Process and Materials for Biomedical Applications |
| US20070138692A1 (en) * | 2002-09-06 | 2007-06-21 | Ford James D | Process for forming clear, wettable silicone hydrogel articles |
| US6958169B2 (en) | 2002-12-17 | 2005-10-25 | Bausch & Lomb Incorporated | Surface treatment of medical device |
| US7628810B2 (en) | 2003-05-28 | 2009-12-08 | Acufocus, Inc. | Mask configured to maintain nutrient transport without producing visible diffraction patterns |
| US20050046794A1 (en) | 2003-06-17 | 2005-03-03 | Silvestrini Thomas A. | Method and apparatus for aligning a mask with the visual axis of an eye |
| US20060004165A1 (en) * | 2004-06-30 | 2006-01-05 | Phelan John C | Silicone hydrogels with lathability at room temperature |
| US9248614B2 (en) * | 2004-06-30 | 2016-02-02 | Novartis Ag | Method for lathing silicone hydrogel lenses |
| US9322958B2 (en) | 2004-08-27 | 2016-04-26 | Coopervision International Holding Company, Lp | Silicone hydrogel contact lenses |
| US20060063852A1 (en) * | 2004-08-27 | 2006-03-23 | Asahikasei Aime Co. Ltd. | Silicone hydrogel contact lens |
| CN101023148B (en) * | 2004-09-20 | 2012-09-12 | Lg化学株式会社 | Carbazole derivative and organic light-emitting device using the same |
| US20060113054A1 (en) * | 2004-12-01 | 2006-06-01 | Silvestrini Thomas A | Method of making an ocular implant |
| US7976577B2 (en) | 2005-04-14 | 2011-07-12 | Acufocus, Inc. | Corneal optic formed of degradation resistant polymer |
| JP2006335925A (en) * | 2005-06-03 | 2006-12-14 | Jsr Corp | Sulfonic acid group-containing polymer, method for producing the same, and polymer composition |
| CA2618035A1 (en) | 2005-08-10 | 2007-02-15 | Novartis Ag | Silicone hydrogels |
| US8153726B2 (en) | 2005-09-30 | 2012-04-10 | The Lagado Corporation | Highly oxygen permeable rigid contact lenses from polyacetylenes |
| US20070116741A1 (en) * | 2005-11-21 | 2007-05-24 | Bausch & Lomb Incorporated | Contact lenses with mucin affinity |
| US7988988B2 (en) * | 2005-11-21 | 2011-08-02 | Bausch & Lomb Incorporated | Contact lenses with mucin affinity |
| US7622512B2 (en) * | 2005-12-21 | 2009-11-24 | Bausch & Lomb Incorporated | Cationic hydrophilic siloxanyl monomers |
| US7759408B2 (en) * | 2005-12-21 | 2010-07-20 | Bausch & Lomb Incorporated | Silicon-containing monomers end-capped with polymerizable cationic hydrophilic groups |
| US20070161769A1 (en) * | 2006-01-06 | 2007-07-12 | Schorzman Derek A | Polymerizable silicon-containing monomer bearing pendant cationic hydrophilic groups |
| US7960447B2 (en) * | 2006-04-13 | 2011-06-14 | Bausch & Lomb Incorporated | Cationic end-capped siloxane prepolymer for reduced cross-link density |
| US7572841B2 (en) * | 2006-06-15 | 2009-08-11 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
| US7540609B2 (en) * | 2006-06-15 | 2009-06-02 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
| US8231218B2 (en) * | 2006-06-15 | 2012-07-31 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
| US8053539B2 (en) | 2006-06-30 | 2011-11-08 | Johnson & Johnson Vision Care Inc. | Siloxanyl materials for molded plastics |
| US8569538B2 (en) | 2006-06-30 | 2013-10-29 | Johnson & Johnson Vision Care, Inc. | Acryloyl materials for molded plastics |
| TW200816966A (en) * | 2006-07-21 | 2008-04-16 | Alcon Mfg Ltd | Low-tack ophthalmic and otorhinolaryngological device materials |
| US7838698B2 (en) * | 2006-09-29 | 2010-11-23 | Johnson & Johnson Vision Care, Inc. | Hydrolysis-resistant silicone compounds |
| US9056880B2 (en) | 2006-09-29 | 2015-06-16 | Johnson & Johnson Vision Care, Inc. | Process for producing hydrolysis-resistant silicone compounds |
| US20080081850A1 (en) * | 2006-09-29 | 2008-04-03 | Kazuhiko Fujisawa | Process for producing hydrolysis-resistant silicone compounds |
| EP2067797B1 (en) * | 2006-09-29 | 2020-11-04 | Toray Industries, Inc. | Silicone polymer, ocular lenses, and contact lens |
| WO2008073711A2 (en) * | 2006-12-12 | 2008-06-19 | Bausch & Lomb Incorporated | Ordered polymer system and intraocular lens |
| JP5669396B2 (en) * | 2006-12-13 | 2015-02-12 | ノバルティス アーゲー | Actinic radiation curable silicone hydrogel copolymers and uses thereof |
| US7832856B2 (en) * | 2006-12-20 | 2010-11-16 | Bausch & Lomb Incorporated | Coatings and solutions for contact lenses |
| US20080151181A1 (en) * | 2006-12-20 | 2008-06-26 | Bausch & Lomb Incorporated | Coatings and Solutions for Contact Lenses |
| US20080152540A1 (en) * | 2006-12-22 | 2008-06-26 | Bausch & Lomb Incorporated | Packaging solutions |
| US7691917B2 (en) | 2007-06-14 | 2010-04-06 | Bausch & Lomb Incorporated | Silcone-containing prepolymers |
| US8080622B2 (en) | 2007-06-29 | 2011-12-20 | Johnson & Johnson Vision Care, Inc. | Soluble silicone prepolymers |
| AU2008286759B2 (en) * | 2007-08-15 | 2014-05-08 | Isp Investments Inc. | Polyvinylamide polymers containing polymerizable functionalities |
| TW200920330A (en) * | 2007-10-02 | 2009-05-16 | Alcon Inc | Ophthalmic and otorhinolaryngological device materials containing an alkyl ethoxylate |
| EP2209824B1 (en) * | 2007-11-16 | 2012-08-08 | Rhodia, Inc. | High definition printing with waterborne inks on non-porous substrates |
| US7897654B2 (en) * | 2007-12-27 | 2011-03-01 | Johnson & Johnson Vision Care Inc. | Silicone prepolymer solutions |
| US8440738B2 (en) * | 2008-07-09 | 2013-05-14 | Timothy Higgs | Silicone hydrogels and methods of manufacture |
| US7939579B1 (en) | 2008-07-09 | 2011-05-10 | Contamac Limited | Hydrogels and methods of manufacture |
| US20100149482A1 (en) * | 2008-12-12 | 2010-06-17 | Ammon Jr Daniel M | Contact lens |
| EP2399555B1 (en) * | 2009-02-20 | 2016-12-07 | Seed Co., Ltd. | Sustainedly drug-releasing hydrogel contact lens, and drug releasing method using sustainedly drug-releasing hydrogel contact lens |
| US9492272B2 (en) | 2009-08-13 | 2016-11-15 | Acufocus, Inc. | Masked intraocular implants and lenses |
| US10004593B2 (en) | 2009-08-13 | 2018-06-26 | Acufocus, Inc. | Intraocular lens with elastic mask |
| WO2011020074A1 (en) | 2009-08-13 | 2011-02-17 | Acufocus, Inc. | Corneal inlay with nutrient transport structures |
| SG175812A1 (en) * | 2009-10-01 | 2011-12-29 | Coopervision Int Holding Co Lp | Silicone hydrogel contact lenses and methods of making silicone hydrogel contact lenses |
| GB0917806D0 (en) | 2009-10-12 | 2009-11-25 | Sauflon Cl Ltd | Fluorinated silicone hydrogels |
| USD656526S1 (en) | 2009-11-10 | 2012-03-27 | Acufocus, Inc. | Ocular mask |
| US9005492B2 (en) * | 2009-12-14 | 2015-04-14 | Novartis Ag | Methods for making silicone hydrogel lenses from water-based lens formulations |
| EP2513712B1 (en) * | 2009-12-17 | 2016-08-10 | Novartis AG | Pad transfer printing method for making colored contact lenses |
| WO2011079380A1 (en) | 2009-12-30 | 2011-07-07 | Axcelon Biopolymers Corporation | Transparent bacterial cellulose nanocomposite hydrogels |
| EP2635622A4 (en) * | 2010-11-02 | 2014-04-16 | 3M Innovative Properties Co | Siloxane graft co-polymers for mold release |
| TWI519844B (en) | 2011-02-28 | 2016-02-01 | 古柏威順國際控股有限合夥公司 | Wettable silicone hydrogel contact lenses |
| AU2012223584B8 (en) | 2011-02-28 | 2014-08-14 | Coopervision International Limited | Dimensionally stable silicone hydrogel contact lenses |
| CN103827175B (en) | 2011-02-28 | 2016-08-10 | 库柏维景国际控股公司 | Silicone Hydrogel Contact Lenses |
| KR101742351B1 (en) | 2011-02-28 | 2017-05-31 | 쿠퍼비젼 인터내셔날 홀딩 캄파니, 엘피 | Phosphine-containing hydrogel contact lenses |
| SG192245A1 (en) | 2011-02-28 | 2013-09-30 | Coopervision Int Holding Co Lp | Silicone hydrogel contact lenses |
| HUE043683T2 (en) | 2011-02-28 | 2019-09-30 | Coopervision Int Holding Co Lp | Silicone hydrogel contact lenses having acceptable levels of energy loss |
| SG192188A1 (en) | 2011-02-28 | 2013-08-30 | Coopervision Int Holding Co Lp | Silicone hydrogel contact lenses and related compositions and methods |
| TWI513768B (en) | 2011-06-01 | 2015-12-21 | Novartis Ag | Hydrophobic acrylic intraocular crystal material |
| TWI551646B (en) * | 2011-06-03 | 2016-10-01 | 諾華公司 | Hydrophobic acrylic intraocular crystal material |
| SG11201400287XA (en) * | 2011-09-01 | 2014-03-28 | Vertellus Specialties Inc | Methods for producing biocompatible materials |
| US9006305B2 (en) | 2011-09-01 | 2015-04-14 | Vertellus Specialties Inc. | Biocompatible material |
| GB201119363D0 (en) * | 2011-11-10 | 2011-12-21 | Vertellus Specialities Inc | Polymerisable material |
| WO2013082545A1 (en) | 2011-12-02 | 2013-06-06 | Acufocus, Inc. | Ocular mask having selective spectral transmission |
| WO2013110911A1 (en) | 2012-01-27 | 2013-08-01 | Contamac Limited | Silicone hydrogels and methods for manufacture |
| US10209534B2 (en) | 2012-03-27 | 2019-02-19 | Johnson & Johnson Vision Care, Inc. | Increased stiffness center optic in soft contact lenses for astigmatism correction |
| US9204962B2 (en) | 2013-03-13 | 2015-12-08 | Acufocus, Inc. | In situ adjustable optical mask |
| US9427922B2 (en) | 2013-03-14 | 2016-08-30 | Acufocus, Inc. | Process for manufacturing an intraocular lens with an embedded mask |
| JP6147211B2 (en) | 2014-03-20 | 2017-06-14 | 信越化学工業株式会社 | Monomers for ophthalmic device manufacturing |
| JP6356635B2 (en) | 2014-06-12 | 2018-07-11 | 信越化学工業株式会社 | Monomers for ophthalmic device manufacturing |
| JP6173260B2 (en) | 2014-06-12 | 2017-08-02 | 信越化学工業株式会社 | Monomers for ophthalmic device manufacturing |
| WO2016057784A1 (en) | 2014-10-08 | 2016-04-14 | Innovega, Inc. | Contact lens and method for constructing a contact lens |
| WO2016081493A1 (en) | 2014-11-19 | 2016-05-26 | Acufocus, Inc. | Fracturable mask for treating presbyopia |
| US9869884B2 (en) | 2014-11-22 | 2018-01-16 | Innovega, Inc. | Contact lens |
| US10208225B2 (en) * | 2015-02-10 | 2019-02-19 | Marcella Chiari | Fluoro copolymers, immobilization of biomolecules, and microarrays |
| ES2972581T3 (en) | 2015-10-05 | 2024-06-13 | Acufocus Inc | Intraocular lens molding methods |
| KR101752862B1 (en) * | 2015-10-12 | 2017-06-30 | (주)메디오스 | photochromic soft contact lens producing method |
| CN108350117A (en) * | 2015-10-29 | 2018-07-31 | Dic株式会社 | Siloxanyl monomers and its polymer, the composition containing the polymer, electronic component |
| JP7055747B2 (en) | 2015-11-24 | 2022-04-18 | アキュフォーカス・インコーポレーテッド | Toric small aperture intraocular lens with extended depth of focus |
| WO2017155552A1 (en) * | 2016-03-11 | 2017-09-14 | Innovega, Inc. | Contact lens |
| US11125916B2 (en) * | 2016-07-06 | 2021-09-21 | Johnson & Johnson Vision Care, Inc. | Silicone hydrogels comprising N-alkyl methacrylamides and contact lenses made thereof |
| JP7233082B2 (en) * | 2017-12-28 | 2023-03-06 | 国立大学法人信州大学 | Optical element, microlens array, and method for fabricating optical element |
| WO2019217471A1 (en) | 2018-05-09 | 2019-11-14 | Acufocus, Inc. | Intraocular implant with removable optic |
| IL296684A (en) * | 2020-03-25 | 2022-11-01 | Kiora Pharmaceuticals Inc | Preparations and methods for the treatment of eye disease by administering drugs via contact lenses |
| US12393057B2 (en) | 2020-12-15 | 2025-08-19 | Coopervision International Limited | Oleic acid-releasing contact lens |
| US12611016B2 (en) | 2020-12-15 | 2026-04-28 | Coopervision International Limited | Cationic contact lens |
| TWI754546B (en) | 2021-02-09 | 2022-02-01 | 望隼科技股份有限公司 | Manufacturing method of contact lenses |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2070169A (en) * | 1935-07-29 | 1937-02-09 | Carl L Braun | Broom or article of analogous nature |
| US2760100A (en) * | 1951-11-26 | 1956-08-21 | Hartford Nat Bank & Trust Co | Electric discharge tube |
| US3228741A (en) | 1962-06-29 | 1966-01-11 | Mueller Welt Contact Lenses In | Corneal contact lens fabricated from transparent silicone rubber |
| US3341490A (en) | 1964-08-13 | 1967-09-12 | Dow Corning | Blends of two polysiloxane copolymers with silica |
| US3808178A (en) | 1972-06-16 | 1974-04-30 | Polycon Laboratories | Oxygen-permeable contact lens composition,methods and article of manufacture |
| USRE33477E (en) | 1973-06-20 | 1990-12-04 | Wesley-Jessen, Inc. | Ultraviolet absorbing hydrophilic corneal contact lenses |
| US3996189A (en) | 1975-04-29 | 1976-12-07 | American Optical Corporation | Optically clear filled silicone elastomers |
| US3996187A (en) | 1975-04-29 | 1976-12-07 | American Optical Corporation | Optically clear filled silicone elastomers |
| US4028295A (en) | 1976-01-08 | 1977-06-07 | Wesley-Jessen Inc. | Hydrophilic polymer and contact lens |
| USRE30368E (en) | 1976-10-12 | 1980-08-12 | Wesley-Jessen Inc. | Gas-permeable lens |
| US4111535A (en) | 1976-10-12 | 1978-09-05 | Wesley-Jessen Inc. | Gas-permeable lens |
| US4109070A (en) | 1977-06-07 | 1978-08-22 | Wesley-Jessen Inc. | Method of producing optically clear hydrophilic copolymers and contact lenses |
| US4136250A (en) | 1977-07-20 | 1979-01-23 | Ciba-Geigy Corporation | Polysiloxane hydrogels |
| US4158089A (en) | 1977-12-27 | 1979-06-12 | Wesley-Jessen Inc. | Contact lenses of high water content |
| US4182802A (en) | 1977-12-27 | 1980-01-08 | Samuel Loshaek | Hydrophilic polymers and contact lenses of high water content |
| USRE31422E (en) | 1977-12-27 | 1983-10-18 | Schering Corporation | Hydrophilic polymers and contact lenses of high water content |
| US4228269A (en) | 1978-06-08 | 1980-10-14 | Wesley-Jessen Inc. | Contact lenses of high gas permeability |
| US4405773A (en) | 1982-02-05 | 1983-09-20 | Schering Corporation | Hydrophylic contact lenses and methods for making same |
| US4711943A (en) | 1985-04-26 | 1987-12-08 | Sola U.S.A. Inc. | Hydrophilic siloxane monomers and dimers for contact lens materials, and contact lenses fabricated therefrom |
| US4686267A (en) * | 1985-10-11 | 1987-08-11 | Polymer Technology Corporation | Fluorine containing polymeric compositions useful in contact lenses |
| US5070169A (en) | 1988-02-26 | 1991-12-03 | Ciba-Geigy Corporation | Wettable, flexible, oxygen permeable contact lens containing block copolymer polysiloxane-polyoxyalkylene backbone units and use thereof |
| AU618817B2 (en) * | 1988-07-05 | 1992-01-09 | Novartis Ag | Dimethylacrylamide-copolymer hydrogels with high oxygen permeability |
| US4954587A (en) * | 1988-07-05 | 1990-09-04 | Ciba-Geigy Corporation | Dimethylacrylamide-copolymer hydrogels with high oxygen permeability |
| US4954586A (en) * | 1989-01-17 | 1990-09-04 | Menicon Co., Ltd | Soft ocular lens material |
| US5070215A (en) | 1989-05-02 | 1991-12-03 | Bausch & Lomb Incorporated | Novel vinyl carbonate and vinyl carbamate contact lens material monomers |
| US5034461A (en) | 1989-06-07 | 1991-07-23 | Bausch & Lomb Incorporated | Novel prepolymers useful in biomedical devices |
| US5032658A (en) * | 1989-10-17 | 1991-07-16 | Polymer Technology Corporation | Polymeric compositions useful in oxygen permeable contact lenses |
| US5177168A (en) * | 1989-10-17 | 1993-01-05 | Polymer Technology Corp. | Polymeric compositions useful in oxygen permeable contact lenses |
| US5314960A (en) * | 1990-04-10 | 1994-05-24 | Permeable Technologies, Inc. | Silicone-containing polymers, oxygen permeable hydrophilic contact lenses and methods for making these lenses and treating patients with visual impairment |
| US5314961A (en) * | 1990-10-11 | 1994-05-24 | Permeable Technologies, Inc. | Silicone-containing polymers, compositions and improved oxygen permeable hydrophilic contact lenses |
| JP2774233B2 (en) * | 1992-08-26 | 1998-07-09 | 株式会社メニコン | Ophthalmic lens materials |
| US5321108A (en) | 1993-02-12 | 1994-06-14 | Bausch & Lomb Incorporated | Fluorosilicone hydrogels |
| JPH07196745A (en) * | 1993-12-28 | 1995-08-01 | Menicon Co Ltd | Ophthalmic lens material |
| US5760100B1 (en) | 1994-09-06 | 2000-11-14 | Ciba Vision Corp | Extended wear ophthalmic lens |
| JP3569373B2 (en) * | 1995-02-15 | 2004-09-22 | 株式会社メニコン | Hydrous soft contact lens |
| EP0729041B1 (en) * | 1995-02-15 | 2001-11-28 | Menicon Co., Ltd. | Water-Absorptive soft contact lens |
| EP0796723B1 (en) * | 1995-09-06 | 2001-12-05 | Menicon Co., Ltd. | Process for producing optic lens and optic lens obtained thereby |
| CA2193149C (en) | 1995-12-22 | 2002-04-23 | David H. Donabedian | Cationic therapuetic agents and delivery systems |
| US5807944A (en) * | 1996-06-27 | 1998-09-15 | Ciba Vision Corporation | Amphiphilic, segmented copolymer of controlled morphology and ophthalmic devices including contact lenses made therefrom |
| JPH11166005A (en) * | 1997-12-03 | 1999-06-22 | Menicon Co Ltd | Manufacturing method of molded body |
| JPH11228643A (en) * | 1998-02-17 | 1999-08-24 | Menicon Co Ltd | Ophthalmic lens material and its manufacturing method |
| CN1299387A (en) | 1998-05-05 | 2001-06-13 | 博士伦公司 | Plasma surface treatment of silicone hydrogel contact lenses |
| US6346594B1 (en) * | 1998-09-21 | 2002-02-12 | Menicon Co., Ltd. | Ocular lens material and process for producing same |
| US6187369B1 (en) | 1998-11-12 | 2001-02-13 | Biocoat Incorporated | Hydrophilic substrates and method of making same |
| US6649722B2 (en) * | 1999-12-10 | 2003-11-18 | Novartis Ag | Contact lens |
-
2000
- 2000-12-06 US US09/731,331 patent/US6649722B2/en not_active Expired - Lifetime
- 2000-12-07 AT AT00982514T patent/ATE406594T1/en not_active IP Right Cessation
- 2000-12-07 WO PCT/US2000/033237 patent/WO2001042846A1/en not_active Ceased
- 2000-12-07 AU AU19536/01A patent/AU1953601A/en not_active Abandoned
- 2000-12-07 DE DE60040090T patent/DE60040090D1/en not_active Expired - Lifetime
- 2000-12-07 CA CA002392298A patent/CA2392298A1/en not_active Abandoned
- 2000-12-07 JP JP2001544077A patent/JP4712265B2/en not_active Expired - Lifetime
- 2000-12-07 EP EP00982514A patent/EP1236068B1/en not_active Expired - Lifetime
-
2002
- 2002-06-03 NO NO20022628A patent/NO20022628L/en not_active Application Discontinuation
-
2003
- 2003-07-09 US US10/470,651 patent/US7201481B2/en not_active Expired - Lifetime
-
2010
- 2010-08-13 JP JP2010181286A patent/JP5198517B2/en not_active Expired - Lifetime
Non-Patent Citations (2)
| Title |
|---|
| No further relevant documents disclosed * |
| See also references of WO0142846A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US7201481B2 (en) | 2007-04-10 |
| NO20022628L (en) | 2002-07-30 |
| WO2001042846A1 (en) | 2001-06-14 |
| AU1953601A (en) | 2001-06-18 |
| JP2011008279A (en) | 2011-01-13 |
| EP1236068A4 (en) | 2007-03-28 |
| US20060012751A1 (en) | 2006-01-19 |
| US6649722B2 (en) | 2003-11-18 |
| EP1236068B1 (en) | 2008-08-27 |
| US20020107337A1 (en) | 2002-08-08 |
| ATE406594T1 (en) | 2008-09-15 |
| CA2392298A1 (en) | 2001-06-14 |
| JP5198517B2 (en) | 2013-05-15 |
| NO20022628D0 (en) | 2002-06-03 |
| JP2003516562A (en) | 2003-05-13 |
| JP4712265B2 (en) | 2011-06-29 |
| DE60040090D1 (en) | 2008-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7201481B2 (en) | Contact lens | |
| US11754754B2 (en) | Silicone hydrogels comprising N-alkyl methacrylamides and contact lenses made thereof | |
| KR101983981B1 (en) | Medical devices having homogeneous charge density and methods for making same | |
| AU2011282604B2 (en) | A silicone hydrogel lens with a crosslinked hydrophilic coating | |
| AU2020270465A1 (en) | Silicone hydrogel contact lenses having nonuniform morphology | |
| KR20120002609A (en) | Method of Making Silicone Hydrogel Contact Lenses and Silicone Hydrogel Contact Lenses | |
| KR20230023541A (en) | Amino acid-based polymerizable compounds and ophthalmic devices made therefrom | |
| EP1927882B1 (en) | Contact lens | |
| RU2855934C1 (en) | Polymerisable amino acid-based compounds and ophthalmic devices obtained therefrom | |
| EP4514596A1 (en) | Method for making silicone hydrogel contact lenses | |
| AU2013203441B2 (en) | A silicone hydrogel lens with a crosslinked hydrophilic coating | |
| HK40080331A (en) | Silicone hydrogels comprising n-alkyl methacrylamides and contact lenses made thereof | |
| HK40008059A (en) | Silicone hydrogels comprising n-alkyl methacrylamides and contact lenses made thereof | |
| HK40008059B (en) | Silicone hydrogels comprising n-alkyl methacrylamides and contact lenses made thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20020508 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: TUCKER, ROBERT Inventor name: CARLSON, GREG Inventor name: QUINN, MICHAEL, H. Inventor name: OCAMPO, GERARDO, J. Inventor name: ROSENZWEIG, HOWARD, S. |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NOVARTIS AG |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NOVARTIS AG Owner name: NOVARTIS PHARMA GMBH |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20070227 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: C08F 230/08 20060101ALI20070221BHEP Ipc: B29D 11/00 20060101ALI20070221BHEP Ipc: G02C 7/04 20060101AFI20010619BHEP |
|
| 17Q | First examination report despatched |
Effective date: 20070511 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NOVARTIS AG |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REF | Corresponds to: |
Ref document number: 60040090 Country of ref document: DE Date of ref document: 20081009 Kind code of ref document: P |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080827 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20081208 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080827 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080827 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080827 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080827 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090127 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081231 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| 26N | No opposition filed |
Effective date: 20090528 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080827 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081207 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081231 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081231 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20081127 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081207 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080827 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080827 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20081128 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 16 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20151201 Year of fee payment: 16 Ref country code: GB Payment date: 20151202 Year of fee payment: 16 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20151110 Year of fee payment: 16 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 60040090 Country of ref document: DE |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20161207 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20170831 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170102 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161207 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170701 |